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Abstract
Assessing the mechanisms underlying adverse cardiovascular effects
induced by inhaled toxins presents a substantial research challenge. We propose
that blood carries an as yet unknown “inflammatory potential” consisting of
modified proteins or other biomolecules and reaction byproducts that affects a
pathological bioactivity which can be assessed using naïve endothelial cells and
blood vessels. The approach involves applying serum from exposed animals to
cultured primary endothelial cells or ex vivo isolated arteries. Mice were exposed
to multi-walled carbon nanotubes (MWCNT; 0, 10 or 40 µg) or other pollutants
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via pharyngeal aspiration and serum was collected at 4 and 24 h post-exposure.
Serum from exposed mice increased endothelial cell surface vascular cell
adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1)
expression and proinflammatory transcripts, and decreased ATP-stimulated nitric
oxide (NO) production. The functional impact of this loss of NO bioavailability
was confirmed via myography, in which serum from pollutant-exposed mice
significantly impaired vasodilation to acetylcholine. In addition, serum from
pollutant-exposed mice reduced cell migration in a traditional scratch assay
experiment. In vivo MWCNT exposure was able to both increase the permeability
of the Blood Brain Barrier (BBB), as well as induce transcription of proinflammatory cytokines in the hippocampus and frontal cortex regions of the
brain. This affect was abolished with the treatment of fasudil, or the absence of
CD36. There was also evidence of astrocyte activation in the short and microglia
activation at 24 hours. CD 36 has also been identified as playing a key role in
mediating loss of vasodilatory properties ex vivo. In conclusion, pulmonary
exposure to MWCNT dynamically alters circulating factors, which promotes
endothelial cell activation, decreased NO bioavailability, and altered functionality
all directionally predicting adverse cardiovascular outcomes.
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INTRODUCTION
1.1 Cardiovascular Disease
According to the world health organization, cardiovascular disease (CVD)
is the number 1 cause of death globally. Presently, more people die from
cardiovascular disease annually than from any other cause. In 2012, an
estimated 17.5 million people died from CVD, this number represented 31% of all
global deaths. CVD includes a wide range of disorders of the heart and blood,
involving a wide range of vascular beds, such as the cerebrovascular (stroke)
and coronary (myocardial infarction, heart failure). These specific beds are of
greatest interest, due to the high frequency of disease incidence and potential for
environmental factors to negatively impact this large population.

The World

Health Organization estimates that inhaled pollutants represent one of the largest
global health concerns, specifically in terms of exacerbating cardiovascular
disease, owing to the commonality of pollutant exposures in the home,
workplace, and ambient environment in many urban regions of the world1,2.
One of the hallmarks of common, chronic CVD, such as atherosclerosis, is
the activation of the endothelium. The endothelium is a layer of cells that line the
vasculature of the body. Under normal conditions the endothelium works to
maintain a state of homeostasis in the body, with blood flowing freely and
accessing the different organs of the body, as needed. However, when vascular
injury occurs, the endothelium becomes “activated”, resulting in three main
outcomes that initiates the process of atherosclerosis3.
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1.1.1 Activation of the Endothelium
The first outcome of an activated endothelium is the expression of
adhesion molecules4 on the surface of the cell, followed by secretion of proinflammatory cytokines5 to both further activate the endothelium as well as
activate circulating monocytes in the blood. Circulating monocytes adhere to the
endothelium, migrate into the sub-endothelial space, and undergo further
differentiation into monocyte-derived macrophages6. This process was originally
thought to be mediated by an abundance of cholesterol and low-density
lipoproteins (LDL) in the body as a result of a bad diet and/or poor lifestyle.
Recent evidence however has found that atherosclerosis has a stronger
inflammatory and immune7 component than originally thought. A recently
identified molecule, called oxidized-low density lipoprotein (ox-LDL)8, has been
identified as one of the primary drivers of this inflammation. Ox-LDL is formed
when LDL particles in blood plasma invade the endothelium and become
oxidized9. This oxidation is the result of a complex set of biochemical reactions
involving enzymes and free radicals in the endothelium.
The initial migration of monocytes into the sub-endothelial space is further
propagated by intracellular signaling through adhesion molecules, including
intercellular adhesion molecule -1 (ICAM-1), vascular cell adhesion molecule – 1
(VCAM-1)10 and various selectins, most notably p-selectin. Monocyte migration
into the interstitial tissue results in the differentiation of monocytes into
macrophages. Macrophage-colony stimulating factor (M-CSF) is required to
catalyze this conversion of monocytes into macrophages11.
2

The second outcome of an activated endothelium is the increased
permeability of the endothelium12-14. Tight junctions can become destabilized,
allowing for gaps in the endothelial cells to form; this is most often the result of
stimulation by cytokines/chemokines and close communication with activated
monocytes15. This increased permeability allows for adherent monocytes to
transmigrate into the sub-endothelial space and eventually differentiate into
macrophages16,17. A second consequence of this increased permeability is the
potential for LDL or ox-LDL to bind proteoglycans in the extracellular matrix and
become trapped in the vascular wall, eventually becoming engulfed by the subendothelial macrophages.
A third consequence of an activated endothelium is the decreased
production of vasodilatory and antithrombotic molecules, primarily through
reduced expression and/or function of endothelial nitric oxide synthase
(eNOS)18,19. eNOS produces the diffusible gas, nitric oxide (NO), which functions
as an endogenous vasodilator, platelet inhibitor, antioxidant and regulator of
vascular endothelium20,21. NO production is a tightly regulated process that is
required in response to diverse physiological and pathophysiological stimuli.
eNOS is regulated by multiple interdependent control mechanisms and signaling
pathways that act throughout the various states of the enzyme’s life history. Intracellular calcium is a critical determinant of eNOS activity; this is due to the fact
that maximal catalytic function of eNOS requires calmodulin22 binding to a 50amino acid domain in order to facilitate transfer of oxygen-derived electrons
between the enzyme’s reductase and oxygenase domains, which facilitates the
3

conversion of L-arginine to L-citrulline plus NO. Normally, eNOS is bound to
membrane invaginations called caveolae; binding of calcium to calmodulin
disrupts this inhibitory binding and allows eNOS to become activated.
Numerous pathways converge on mobilization of intercellular calcium
transients to provide the most rapid mechanisms of eNOS activation via
calmodulin23. A diverse group of agonists, including bradykinin and acetylcholine,
activates a G-protein dependent signaling pathways that ultimately releases
intracellular calcium stores24. In this pathway, phospholipase C cleaves
membrane component phosphatidylinositol 4,5 trisphosphate into diaclyglycerol
and inositol 1,4,5-triphosphate (IP3) which binds to IP3 receptors that are found
in high concentrations in caveolae and regulate intra-cellular calcium through
pleiotropic effects.
In addition to calcium activation of eNOS, phosphorylation and dephosphorylation act as major post-translation regulatory influences on eNOS
activity. Key serine and threonine residues in eNOS regulatory loci include
phosphorylations at Ser 1177, Ser 635, and Ser 617 are stimulatory, while
phosphorylations at Thr 49525, and Ser 116 act to inhibit activation. The
activation of eNOS catalytic function by Ser 1177 phosphorylation is due to
inhibition of calmodulin dissociation from eNOS, as well as enhancement of the
internal rate of eNOS electron transfer. Ser 1177 phosphorylation is catalyzed by
numerous kinases including Akt as well as cyclic AMP-dependent protein kinase,
AMP-activated protein kinase, PKG, and calcium/calmodulin-dependent protein
kinase II26. At present the relative contributions of these different kinases are
4

unknown, but is it known that different extra-cellular stimuli activate distinct
kinase pathways leading to eNOS phosphorylation27. (Figure 1.1)
These

three

adhesion/chemotactic

processes
signaling;

of

endothelial

increased

activation

permeability;

(increased

decrease

NO

production) occur throughout the development of chronic atheromatous lesions in
major blood vessels. In early lesion development, the activated endothelium is
the first step in recruiting macrophages to begin the lesion formation. In latter
stages of atheroma development, the inability to generate NO impairs relaxation
and allows greater activation of circulating platelets.

Importantly, these

endothelial outcomes appear to be triggered by numerous environmental factors
and represent an important biological readout to assess the potency of
exogenous toxicants.

EC Activation
- ↑ permeability
- ↑adhesion of
monocytes
- Relocalization and
uncoupling of eNOS
Figure 1.1: Initial Consequences of an activated endothelium.
Activation of the endothelium results in increased permeability, increased adhesion of circulating
monocytes, and uncoupling of eNOS.

1.1.2 Risk Factors for CVD
Risk factors for CVD include both modifiable and non-modifiable risk
factors. Non-modifiable risk factors include age, male gender due to the lack of
5

the cardio protective properties of estrogen, and a family history of CVD at a
young age. Modifiable risk factors include lifestyle and environmental exposures
that can be impacted by changes in behavior, diet, or medication, such as
dyslipidemia, or elevated LDL and decreased HDL, smoking or other toxicant
exposures, hypertension, and obesity. The risk factor we are most interested in is
modifiable environmental exposures, specifically the inhalation of airborne
particulates.

1.2 Particulates
Particulates are defined as microscopic solid or liquid matter suspended in
earth’s atmosphere28. Particulates have been designated a group 1 carcinogen
by the WHO and are heavily associated with asthma and lung cancer, but also
premature death and increased risk of hospitalizations, especially as related to
CVD outcomes. Respirable particles have an aerodynamic diameter of 10
micrometers or less, with fine particles having a diameter of <2.5 micrometers
and ultrafine particles having a diameter of <0.1microns or 100 nanometers.

1.2.1 Toxicity of Particulates
The size of a particle is the most important determinant of its toxicity,
which partially determines its reactive surface area, as well as where in the
respiratory tract it will deposit, once inhaled29. Larger particles (2.5-10 microns)
are generally filtered in the nose and throat, but smaller particles can settle
deeper in the lungs and bronchi and cause more significant health problems30.
Fine or ultrafine particles, due to their small size, can penetrate into the gas
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exchange (alveolar) regions of the lung. While size is a large determinant of the
toxicity and the depth of penetration of particles, shape and chemical
composition play a role, as well. In general, inhalable particles penetrate the
airways no further than the bronchi and are quickly removed out by the
mucociliary tract of the major conduit airways, where they are swallowed or
expectorated. Smaller particles can penetrate into terminal bronchioles and the
alveoli, the deep region of the lung where gas exchange occurs, where they must
be removed by alveolar macrophages. These smaller particles that penetrate
deep into the airways necessarily will have a prolonged retention time and the
potential for greater toxicity.

1.3 Lung Defenses
The lungs have the largest surface area of the body, approximately the
size of a tennis court, and as a result are exposed to a wide range of pathogens,
toxins, and allergens. To combat this, the lungs employ a wide range of
defenses. These defenses include the mucociliary escalator, xenobiotic
metabolism, the innate immune system, and the epithelial lining fluid (ELF).

1.3.1 Mucociliary Escalator
The portion of the respiratory tract that conducts air into the gas exchange
region of the lungs is largely lined with a ciliated airway respiratory epithelium. A
thin fluid film of mucus, derived from secretory goblet cells, surrounds cilia. On
top of that is a second viscous film of mucus, in which deposited foreign particles
and microorganisms become trapped. Within the thin fluid film of mucus the cilia
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act out movements coordinated in direction towards the pharynx. Thereby, the
viscous film of mucus, including its freight, is transported away in direction
towards the mouth, where it is either swallowed or expelled via coughing.
Important for effective mucociliary clearance are the number of cilia, their
structure, activity, and coordinated movement. Optimal functionality of the cilia
requires a specific temperature and humidity31. Conditions of insufficient
temperature and humidity can result in the ciliary cells suspending their transport
function. Under such circumstances, bacterial germinal colonization is facilitated.
Pulmonary infections and damaging of the pulmonic tissues may result. The
mucociliary escalator generally functions to remove larger particles that deposit
in the upper airways; smaller particles or gases require the lungs to employ other
defense mechanisms32.

1.3.2 Xenobiotic Metabolism
The lungs also contain a wide range of xenobiotic metabolizing
cytochrome p450s33, located largely in airway club cells (previously termed Clara
cells). These xenobiotic enzymes include cyclo-oxygenases and flavine
dependent monooxygenases, as well as phase II conjugating enzymes such as
glutathione S-transferases, UDP-glucuronyltransferases, and DT-diaphorases.
All of these enzymes play a role in the early cellular defense against acute and
delayed pulmonary toxicity. The susceptibility of the lung to xenobiotics depends
on the metabolic balance between toxication and detoxication pathways34.
Notably, as all blood flows through the lung in a given circuit, the lung is highly
responsible for the condition and content of the blood. Major metabolic pathways
8

for regulation of blood volume, such as angiotensin converting enzyme, are
predominantly located in the lung tissue.

1.3.3 Anti-oxidants and the Lung Surfactant
In the alveoli of the lower respiratory tract, the functional interface between
the atmosphere and the body is found, allowing the exchange of oxygen and
carbon dioxide between air and blood. As a result of this interface, the cells
composing the alveolar walls are placed under a burden of toxic oxygen radicals
that is often found to be greater than that of any other tissue. The parenchymal
cells of the lower respiratory tract are able to suppress the intracellular burden of
oxidants with a wide array of anti-oxidants that include superoxide dismutase
(SOD)35, catalases36, and the glutathione system37. These anti-oxidants function
to either convert oxidants to water and oxygen, or to make them water-soluble so
they become easier to excrete. The anti-oxidant defense systems of the
parenchyma are well characterized, but the unique situation of the alveolar
structures with their potential exposure to a wide range of oxidants in the
extracellular milieu, creates the possibility that there may be more oxidant
defense mechanisms that would serve as more of a first line of defense out of the
parenchymal cells.
Additionally, in the deep lung as well as lining the conducting airways,
there is a phospholipid surfactant layer that contains high concentrations of antioxidants such as urate, ascorbate, and glutathione. This surfactant is typically
very thin, to avoid compromising the gas exchange in alveoli or mucociliary tract
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action of the upper airways, but very effective in scavenging reactive gaseous air
pollutants38.

1.3.4 Alveolar Macrophages
In the deepest regions of the lungs the last line of defense is the presence
of alveolar macrophages39. Alveolar macrophages (AMs) serve as the primary
phagocytes of the innate immune system, clearing the air spaces of infectious,
toxic, or allergic substrates that have evaded the defenses of the respiratory
tract, such as nasal passages and the mucociliary escalator40, or formed in situ.
AMs employ secretion of oxygen metabolites, lysozyme, antimicrobial peptides,
and proteases to help eliminate pathogens. In addition to their phagocytic
capabilities, recent evidence suggests that AMs have an equally important role in
resolving inflammation within the airspace. As an inflammatory response
subsides, neutrophils in the lung undergo apoptosis. During apoptosis, neutrophil
surface membranes remain intact, containing their potentially tissue damaging
cytoplasmic contents. If apoptotic neutrophils are not efficiently cleared,
devitalized neutrophils further degrade and leak their proteases into the alveolus,
producing further tissue injury and perpetuating inflammation. Phagocytosis of
neutrophils reduces macrophage secretion of pro-inflammatory cytokines and
also stimulates production of anti-inflammatory cytokines, such as transforming
growth factor-β and interleukin-1041,42.
AMs have proven to be extremely efficient at clearing inhaled particles.
Particles they were unable to phagocytize, such as asbestos, have resulted in
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long-term health effects. Termed “frustrated” macrophages, long fibers that are
morphologically impossible to phagocytize can lead to accumulation of immune
cells and focal regions of inflammation and remodeling43,44. Particles with a high
ascpect ratio of concern to public health include carbon nanotubes. These
engineered particles share morphological characteristics with asbestos and have
raised concerns regarding potential for inefficient alveolar removal.

1.4 Carbon Nanotubes
Presently >100 tons of nanotubes are produced each year, or roughly 1/3
of all nanoparticles created that are carbon-based. Their unique physiochemical
characteristics allows for a wide range of biological effects. Most importantly,
their small aerodynamic size creates the potential for them to penetrate deeply
into the alveolar regions of the lungs. One result of such a high volume of
production is the increased probability for accidental exposures to occur in an
occupational setting, with inhalation of particles having the potential for the
greatest amount of toxicity.

1.5 Multiwalled Carbon Nanotubes (MWCNTs)
MWCNTs are a subset of nanotubes that are highly desired to their ability
to withstand a high degree of functionalization45. This means that they are ideal
platforms for a number of different applications including electronics, consumer
goods, imaging, and as drug delivery platforms46. MWCNTs consist of graphene
that has either been rolled around itself, dubbed the “parchment model” due to its
resemblance to rolled parchment. Or they can consist of sheets of graphite
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arranged in concentric cylinders, e.g. a single-walled nanotube within a larger
single-walled nanotube. The number of layers can vary from 2−50 depending on
the desired properties of the nanotubes. (Figure 1.2)

Figure 1.2: Model of a Multiwalled Carbon Nanotube.
An example of the Russian Doll model of MWCNTs.

1.5.1 Properties of MWCNTs
MWCNTs are the strongest and stiffest materials yet discovered in terms
of tensile strength and elastic modulus respectively47. These two properties are
chief among the reasons they are so highly desired. Their strength results from
the sp2 bonds that form between the individual carbon atoms48. A comparison of
their mechanical properties to other well-known materials indicates that their
strength exceeds that of both Kevlar and stainless steel, respectively.
The symmetry and unique electronic structure of graphene, the parent
substrate of MWCNTs, strongly affects the electrical properties of MWCNTs. For
a given (where n=length,and m=external diamter) nanotube, if n=m the nanotube
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is metallic; if n-m is a multiple of 3 then the nanotube is semiconducting with a
very small band gap, otherwise the nanotube is a moderate semiconductor48.
The mechanical properties of MWCNTs allow them to undergo a high
degree of manipulation, but during this process the potential for crystallographic
defects can occur and, as such, alteration of the material properties. Defects can
occur in the form of atomic vacancies, high levels of which can dramatically lower
the tensile strength of the nanotube, i.e. enhancing the fragility of the tubes.
Defects can also result in loss of electrical properties and thermal conductivity,
with the size of the defect being the biggest determinant of the loss of electrical
and thermal conductivity49.

1.5.2 Surface Characteristics
Many of the unique properties of MWCNTs can be attributed to the
interactions that occur at the surface. In the absence of any kind of surface
coating, MWCNTs are highly lipophilic and tend to aggregate in liquid
suspensions, instead of staying evenly dispersed50. Coating with surfactant is an
example of a surface modification that can prevent the aggregation of nanotubes,
and is an important consideration in the conduct of the present research45. The
degree of nanotube dispersion in a composite material is based on the nanotube
surface interaction with the surrounding material or solution. Toxicity, gas
adsorption, and catalytic activity are all strongly affected by the surface
characteristics. The small size of nanoparticles results in a tremendous amount
of surface area and increases the potential for toxicity. Surface area
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measurement of carbon nanotubes is most commonly based upon N2 gas
adsorption. Surface area measurements must be performed at the boiling point
of absorbate, this makes the use of nitrogen even more appealing due to the fact
that liquid nitrogen is very readily available51.

1.5.3 Density
Density of carbon nanotubes is important for several reasons; it helps
determine the mass of the particle, the aerodynamic behavior that determines
pulmonary deposition, as well as the degree of functionalization that can be
achieved. Currently, three different kinds of density are generally assessed.
These include the bulk density, skeletal density, and the packing density. These
three types of densities are all taken into account when determining the
manipulation of the nanotube in pursuit of a final outcome52.

1.5.4 Current Applications
The many desirable properties of MWCNTs have created the potential for
a number of applications across a wide range of industries. Unfortunately, the
process of scaling nanotubes from the individual tube to a finished product has
presented numerous challenges. Current use and application of nanotubes has
been limited to the use of bulk nanotubes, which translates to a mass of
unorganized fragments of nanotubes53. Presently, bulk nanotube material is
unable to achieve a tensile strength that is on par to that of the individual tubes.
Despite this, bulk composites may still be able to yield strengths sufficient for
many applications54. In spite of this inability to maintain the tensile strength of
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individual particles, bulk carbon nanotubes have already been used as composite
fibers in polymers to strengthen the applications of the composite. Nanotubes
can currently be found in bicycles, airplanes, wind turbines, skis, and baseball
bats.

1.5.5 Synthesis of MWCNTs
There currently exist multiple methods to fabricate nanomaterials
depending on the desired properties. The most common method currently used
to fabricate nanotubes is called plasma arcing. This method employs plasma,
which is an ionized gas. A potential difference is placed between two electrodes
and the gas in between ionizes. A typical arcing device is made of two electrodes
and an arc that passes from one electrode to the other. The first electrode
vaporizes as electrons are taken from it by the potential difference. These
positively charged ions pass to the other electrode, pick up electrons and are
deposited to form nanotubes.
The

second

most

common

technique

employed

to

synthesize

nanomaterials is called chemical vapor deposition. In this method, the material to
be deposited is first heated to its gas form and then allowed to deposit as a solid
on a fmetal catalyst. The deposition can be direct or through a chemical reaction
so that the material deposited is different from the volatilized. This process is
normally performed under vacuum and is used to make nanopowders of oxides
and carbides of metals. At present, chemical vapor deposition is the most
promising method for low-cost, large-scale production of MWCNTs55.
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1.6 Occupational Exposure to MWCNTs
As mentioned previously, >100 tons of nanotubes are synthesized each
year. When CNT synthesis moved from the lab to factories and the products
became more widespread, there was a great concern about the toxicity of these
fibrous materials and the potential for exposure in an occupation setting56. The
occupational workforce handling CNT and carbon nanofiber (CNF) currently
employs 500 workers at 61 different companies in the US with an expected
growth rate of 22% annually57. Economically, the global market shows that CNTs
represent 28% of the total engineered nanomaterial market share, with MWCNTs
accounting for 94% of the total CNT production value.
Carbon nanotubes were discovered 25 years ago, but have only entered
the realm of large scale manufacturing in the last 10 years. A result of this very
recent growth in production has limited epidemiological research detailing the
long-term effects of workplace exposures to CNTs. Exposure to CNTs is
currently assessed via sampling of a worker’s Personal Breathing Zone (PBZ).
PBZ samples are attached to the lapel of the worker while the area samplers are
positioned within three feet of the specific process. Direct reading measurements
are then co-located to assess a number of different factors including particle
number, active surface area, and respirable mass58,59.
Early exposure assessment on CNT materials focused on collecting
samples to estimate CNT mass gravimetrically, which does not differentiate CNT
from other airborne dusts. Studies based on total gravimetric mass reported
inconsistent data. These studies reported concentrations ranging from not
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detectable (ND) to 331.7µg/m3. A study by Maynard et al estimated the inhalable
mass of CNFs based on the concentration of metal catalyst and reported PBZ
exposures ranging from 0.7-53µg/m3,60. Studies that quantified CNT as respirable
PBZ elemental carbon (EC) found CNF exposures ranging from 45 to 80µg/m3,61.

1.6.1 Methodology to Assess MWCNT Exposure and Toxicity
To better understand the potential health risks of MWCNT, not only is
information

on

exposure

needed,

but

also

the

concentration-response

relationship for adverse health outcomes. Ideally, controlled MWCNT exposure
research would be conducted in human subjects to get an accurate
representation of the health consequences of exposure, but medical and ethical
principles limit the extent of such research. Aside from that, animal inhalation
exposure would be the most appropriate means to assess the toxicity of
nanotubes in the lungs. This approach also presents many challenges. Inhalation
exposures are often time consuming, expensive, and require special equipment
to conduct correctly. Other factors associated with conducting an inhalation study
include difficulty in generating a controlled CNT concentration, monitoring particle
size and maintaining the exposure level throughout the duration of the
experiment.
The technical difficulty and cost associated with inhalation exposure
forced scientists to assess the effects of CNT exposure in the lung in an
alternative manner. A process termed intratracheal instillation (ITI) was
developed62,63. ITI administers nanotubes in a bolus into the trachea of a small
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animal, and relies upon the idea that the nanotubes will be drawn deeper into the
lung during breathing. One factor that must be taken into account when utilizing
this route of exposure is to choose the appropriate delivery vehicle. An ill-chosen
delivery vehicle can result in aggregation of the nanotubes and prevents both the
delivery into the deep portions of the lungs, as well as failing to achieve a uniform
distribution. This type of exposure does employ an unnatural route of
administration and causes a great deal of stress to the animal as a result of the
traching process. An appropriately designed ITI study including carefully chosen
doses and the appropriate reference compounds does allow for an accurate
assessment of the toxicity of the test material in respirable doses64,65. It is worth
noting that exposures given by ITI have resulted in similar toxicity in the lungs
when compared to inhalation66.
It has been further refined to a method known as pharyngeal aspiration
(PA), which is especially valuable in mice where IT is challenging. Briefly, an
animal is put under light anesthesia and hung from their teeth so their mouth is
open. The tongue is then pulled to the side and a dose of nanotubes, suspended
in a physiologic dispersion media, is slowly pipetted to the back of the throat,
allowing the animal to aspirate the particle-containing solution as they come out
of the anesthesia. When compared to IT, it allows for a better distribution of the
particles in the lungs and causes less stress to the animal. As with IT,
appropriate delivery vehicles and doses must be chosen to ensure a level of
toxicity comparable to inhalation67.
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1.7 Respiratory Health Effects of MWCNTs
As the production of nanotubes increased the potential for exposure in the
workplace became more apparent, researchers stepped in to determine if there
was the potential for any type of toxicity in the lungs following an exposure.
Researchers have conducted studies in mice and rats utilizing both IT and PA
exposures, they have found a number of effects including: inflammation, fibrosis,
granulomas, and cytotoxicity68-70. Two of the more relevant studies will be
covered here.
The first study was conducted in rats by Muller et al testing two forms of
MWCNTs: unprocessed and those that had been ground. The ground MWCNTs
became carbon black, which has a smaller surface area and density when
compared to the unprocessed MWCNTs. Sprague-Dawley rats were given a
single IT dose of either 0.5, 5, or 5mgs of MWCNTs in their lungs and 60 days
later the researchers analyzed the lungs for markers of inflammation. They found
evidence of inflammation, granuloma formation, and fibrosis. This study
suggested the toxic potential for MWCNTs but the doses employed for ITI
exposure were extremely high and unlikely to occur in an occupational setting71.
To date Porter et al has conducted the most thorough study investigating
the pulmonary toxicity of MWCNT exposure utilizing a PA exposure. Their study
investigated the dose-response and time course of MWCNTs in mice to assess
their ability to induce pulmonary inflammation, cytotoxicity, and fibrosis. The
authors of this study employed doses ranging from 10µg to 80µg. They also
assessed their various end points at 1 day following exposure, and explored out
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to 56 days to assess whether any persistent effects remained. The authors found
significant increases in neutrophils in the BALF, lactate dehydrogenase (LDH)
and albumin across all doses, with most peaking at either 1 or 7 days following
exposure. By 56 days these markers were still elevated but were reduced and
presumably returning to baseline. Fibrosis was also evident in all groups at all
time points. An interesting finding from this study separate from the toxicity in the
lungs was light micrograph evidence of AMs that had taken up multiple
MWCNTs. This indicated that MWCNTs could be phagocytized and cleared by
AMs72,73. The implication of this AM clearance is that, unlike asbestos, concerns
regarding pulmonary persistence of MWCNTs are largely mitigated.

1.8 Systemic Effects of MWCNTs
While the adverse respiratory effects of MWCNTs are well established, the
systemic effects associated with MWCNTs are still being established. Presently,
MWCNT exposure is known to induce systemic inflammation, immune
suppression, and has been shown to exacerbate the progression of
cardiovascular disease. These studies have included both PA and inhalation
exposure methodologies. Mechanistic studies that describe pathways by which
systemic organs are negatively affected by inhalation are currently lacking,
although one was proposed for the manner in which MWCNTs exert their
immunosuppressive effects.
The laboratory of Peter Møller and Steffen Loft conducted research
investigating the association between pulmonary exposure to MWCNT and a
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plaque progression. ApoE-/- mice were fed a high fat diet to accelerate the
development of plaque progression while simultaneously being exposed to
MWCNTs. The authors analyzed liver and lung tissues and found gene
expression responses related to oxidative stress (heme-oxygenase 1),
inflammation (CcL2 and NOS2), and vascular activation (VCAM-1 and VEGF-A).
They also found evidence for plaque progression in the aorta as a result of
nanotube exposure, an effect not seen in WT mice74.
Erdely et al conducted a study utilizing a single dose of MWCNTs to
evaluate the immediate systemic response following exposure, characterized by
increased gene expression in circulating white blood cells as well as soluble
proteins released into the circulation. They found that following exposure
increases in biomarkers of a neutrophilic response, including CXCL2, IL-8r, and
Mac-1. Genes associated with stress including Hif-3α, MMP-9, and arginase II
were up regulated. Inflammatory serum proteins were also up regulated including
IL-6, IL-5, CCL-11 and CCL2275.
Erdely et al followed this study up with one looking at some of the longer
term systemic effects following MWCNT exposure. This study found that at 24
hours following MWCNT exposure there was a significant increase in levels of
acute phase proteins including C-reactive protein (CRP), haptoglobin, and serum
amyloid P (SAP) in the serum. They further confirmed these findings by showing
significant elevations of serum amyloid A1 (SAA-1), SAP, and haptoglobin gene
expression in the liver75,76.
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Lastly MWCNT exposure has been associated with systemic immune
suppression. Mitchell and colleagues63 conducted a whole body inhalation
exposure to MWCNTs to assess their interaction on the immune system. Immune
function measurements of splenic cells following MWCNT exposure showed
suppressed T-cell dependent antibody responses, decreased proliferation of T
cell following mitogen simulation, and altered natural killer (NK) cell killing. These
results were accompanied by increased NQO1 and IL-10 gene expression in the
spleen, but not in the lung. The authors followed up this study by elucidating the
mechanism responsible for the systemic immunosuppression they observed as a
result of MWCNT inhalation. The results of this study found that Transforming
Growth Factor-β (TGF-β) was released from the lung upon inhalation exposure to
MWCNTs. This cytokine activated the cyclooxygenase pathway in the spleen
leading to prostaglandin and IL-10 production and release ultimately resulting in
T cell dysfunction and altered systemic immunity77,78.
Taken together, these data provide strong evidence that inhaled MWCNTs
exert systemic effects across multiple organs. The time table following exposure
could help explain pro-inflammatory effects as well the evidence for altered
immune function. The mechanism(s) underlying the pro-inflammatory effects that
extend beyond the lung, however, remain largely unknown.
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1.9 Mechanisms through which Inhaled Particles Cause Systemic Effects
There are currently three different ideas that have been promulgated to
explain the how inhaled toxicants cause systemic effects. All three ideas as well
as any supporting evidence are described below.

1.9.1 Direct Translocation of Particles
The first idea that was proposed was the theory that particles had the
ability to directly translocate from the alveolar regions of the lungs into the
systemic circulation79. As a result of this translocation, particles would be able to
directly interact with the endothelium resulting in an activated endothelium and
the initiation of a pro-inflammatory state. Research on the deleterious effects of
other forms of inhaled particulate matter in the early 90’s led to the idea first
being proposed that particles had the ability to directly translocate from the lungs
to the systemic circulation. With the advent of nanotechnology in the past 15
years, this idea of direct translocation was reignited.
At present the literature on the translocation of very small particles from
the lungs into the blood is limited and conflicting. While inhaled particles can
translocate beyond the lung, the uptake is inefficient and the few observations of
particulates physically located at extrapulmonary sites (such as the heart or
brain) have not been able to establish that those translocated particles are
exerting a toxic effect. A study utilizing human volunteers reported deposition
and clearance by 2 hr of an ultrafine technetium-99m-labeled aerosol. No
significant radioactivity was found in the liver or the blood following exposure80.
Kawakami et al have reported the presence of radioactivity in blood immediately
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after inhalation of

99m

Tc-Technegas in human volunteers81. Experimental animal

studies have reported extra pulmonary translocation of ultrafine particles via IT or
inhalation exposure82-85. Other studies have detailed the ability of IT exposure to
promote thrombosis and adversely affect cardiac function86. While these studies
indicate that particles, specifically those in the ultrafine range, do have the ability
to translocate, the amount that actually makes it into the blood and
extrapulmonary organs differs significantly between studies. While there is no
clear consensus the majority of studies have found that while translocation of
particles can occur, it generally results in a very small amount of particles making
it into the systemic circulation. Further detracting from this theory is the fact that
direct exposures of systemic cells (such as endothelial cells or cardiomyocytes)
to particulate matter typically require in excess of 1,000,000-fold greater
concentrations than are observed even in occupational settings (e.g. 10-100
µg/ml in cell culture, compared to 10-100 µg/m3 in the air) to induce measureable
adverse effects. This small amount of particles suggests that other mechanisms
are responsible for the systemic effects observed following pulmonary particle
exposure.

1.9.2 Activation of the Autonomic Nervous System
The second mechanism proposed to explain the systemic effects of
particles involves activation of the autonomic nervous system87-89. This
mechanism posits the idea that particle inhalation activates airway sensory
nerves, which due to neural plasticity, can modify autonomic nervous system
control of cardiovascular function. This neural plasticity can manifest in both the
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short-term and long-term. Changes in autonomic tone are often the most
immediate response of particle exposure and involve several different reflex
arcs86,90. Much of the evidence linking changes in cardiac autonomic tone with
exposure to particles comes from studies observing Heart Rate Variability (HRV).
HRV is defined as the degree of difference in the inter-beat intervals of
successive heartbeats and is considered an indicator of the balance between
sympathetic and parasympathetic branches of the ANS91. Increased HRV has
traditionally been considered positive because the heart has the ability to
respond rapidly to changing environments. Descreased HRV, reflecting
increased sympathetic tone, is generally associated with an increased risk of
cardiac arrhythmia92 and an increased risk of mortality in people with heart
disease93,94. Research has found low HRV to be associated with exposure to PM
and ozone95-99, while other studies have demonstrated associations between PM
exposure and increased HRV100,101. While the mechanisms triggering changes in
HRV, and thus autonomic tone, have not been fully delineated and are likely
numerous and diverse in nature, the best studied is associated with pulmonary
neural reflexes. While activation of the ANS as a result of exposure to particles
has stronger supporting evidence than the translocation theory, it fails to fully
explain the relationship between particle exposures and cardiovascular disease.
This theory is likely most pertinent in early responses to exposures (i.e., within
hours), while the latter stages of exposure response (hours to days) are
influenced by factors derived from lung interactions that “spill over” into the
circulation102.
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1.10 Spillover of Inflammatory Mediators from the Lung
The third mechanism that has been proposed, dubbed the “spillover”
hypothesis, and the one that has the largest body of supportive evidence, states
that particle exposure elicits its effects by triggering pulmonary oxidative injury
and systemic inflammation with an increase in pro-inflammatory biomarkers. This
local response can lead to systemic oxidative stress and inflammation
characterized by an increase in activated white blood cells, platelets and cytokine
expression. The major consequence of this theory is that the resultant systemic
inflammation injures the vascular endothelium, promoting vasoconstriction,
thrombosis, and inflammation103. Kaufman et al found that inhalation of diesel
exhaust in healthy human subjects caused an increased platelet count 22 hours
following exposure104. This observation was also seen in mice exposed to
concentrated ambient particles that showed an increase in their platelet count
with evidence of platelet activation105.
Van Eeden et al showed that human alveolar macrophages produce
TNF-α in a dose dependent manner when exposed to atmospheric particles106.
Kido et al found the lung to be a major source of systemic circulating IL-6 levels
in mice exposed to ambient PM107. These observations are in line with a large
cohort study by Boucud et al that found significant positive associations of shortterm exposure to PM10 with circulating IL-1β, IL-6, and TNF-α levels108.
Mercer and colleagues at NIOSH conducted one of the most thorough and
compelling studies in support of the spillover hypothesis. The purpose of this
study was to determine the fate of MWCNTs in the body following an inhalation
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exposure. Mice were exposed to whole-body inhalation of MWCNTs at 5 mg/m3,
for 5 hours/day for 12 days. At 1 and 336 days after the 12-day exposure, mice
were anesthetized and lungs, lymph nodes, and extra pulmonary tissues were
analyzed to determine the number of MWCNTs per gram of tissue as a
percentage of the lung burden the mice were exposed to. The authors found that
following exposure, the largest number of particles was found in lymph nodes,
followed by the liver. The heart and brain each had <0.01% of the total number of
particles; given that both of these organs receive a disproportionately high
volume of blood flow to support the high metabolic needs, this lack of uptake was
telling. From this data the authors concluded that while MWCNTs did have
limited ability to translocate from the lungs to the systemic circulation, the
numbers of particles getting through the lungs was insufficient to account for the
adverse effects associated with particle exposure, providing more evidence to
the idea that another mechanism must be responsible for the observed effects.
Recently our lab has published a number of studies providing further
support for the spillover hypothesis; specifically the idea that following exposure
an inflammatory signal arises that is carried in the serum component of the
blood. A study by Channell et al found that human serum was able to induce
gene expression of VCAM-1 when incubated on primary human endothelial cells
following exposure to either diesel or nitrogen dioxide109. Robertson and
colleagues found that serum from mice exposed to ozone, a reactive gas that is
unable to translocate beyond the lungs, was able to significantly decrease the
ability of eNOS mediated relaxation ex vivo110. This effect was abolished in the
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absence of CD 36, a class B scavenger receptor that has been shown to play a
role in a wide range of diseases including atherosclerosis111. Importantly, these
studies did not observe increases in circulating inflammatory factors, such as Creactive protein or TNFα, which might explain the increased bioactivity of the
serum/plasma. It was hypothesized that perhaps modified proteins or peptide
fragments arising from extracellular protease activity might be a driver of
systemic effects.
This serum bioactivity can be assessed in multiple ways across a range of
end points. Incubation of exposed serum on naïve cells or vessels can be used
for both gene expression or vessel reactivity. Serum bioactivity bolsters the
argument that inflammatory spillover is a possible mechanism for the manner in
which inhaled pollutants cause systemic effects. The origin of those circulating
bioactive factors remains unknown, although evidence from earlier work
suggests that air pollution-triggered proteolytic activity in the lungs may lead to
degraded or fragmented peptides that have altered biological activity. Matrix
metalloproteinase 9 (MMP9) was noted as a potential mediator of such
fragments112. Additionally, it is unknown how factors in the serum may act on the
endothelium, but important information from exposure to other inhaled pollutants,
such as ozone or ambient particulate matter suggests that scavenger receptors
such as CD36113, TLR4114, or LOX-1115 may be central mediators of endothelial
cell activation.
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1.11 Matrix Metalloproteinase
One of the studies conducted by Erdely et al included a chart of the
various pro-inflammatory mediators that were measured following a MWCNT
exposure and whether that mediator went up, down, or was unchanged. (Table
1.1)

Name

Lung RNA

Blood RNA

Serum Proteins

IL-1β (ng/mL)

!

!

!

CD 40 (pg/mL)

!

!

!

CCL11(pg/mL)

!

!

!

IL-5(ng/mL)

!

!

!

IL-6(pg/mL)

!

!

!

CXCL1(ng/mL)

!

!

!

CCL22(pg/mL)

!

!

!

MMP-9(ng/mL)

!

!

!

Osteopontin
(ng/mL)
CXCL2(pg/mL)

!

!

!

!

!

!

!
Table 1.1: Chart of inflammatory mediators and their response to MWCNT exposure.
While various mediators were altered following MWCNT exposure, MMP-9 was the only enzyme
consistently found to up-regulated across all measured samples.

Close inspection of this table revealed one mediator, MMP9, was up
regulated in both lung and blood gene expression, as well as in the serum. Matrix
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metalloproteinases are zinc-dependent endopetidases that are capable of
degrading a wide range of extracellular matrix proteins. They are known to be
involved in cleavage of cell surface receptors, the release of apoptotic ligands,
and are thought to play a role in cytokine inactivation116. MMP-9 in particular
utilizes a collagen-based substrate that it can further cleave into distinct
fragments.

MMP-9 is secreted by a wide number of cell types, including

neutrophils, macrophages, and fibroblasts. MMP-9 degrades ECM with
subsequent activation of major proangiogenic factors such as vascular
endothelial growth factor117,118. Macrophages have shown to be a potent source
of MMP-9 secretion119,120, this is important because MWCNT exposure has been
shown to elicit a large number of alveolar macrophages following exposure. The
fragments generated by MMP-9 have been shown to result in a positive feed
back loop that induces the expression of both MMP-9 mRNA and protein.

1.12 Scavenger Receptor, CD36
Once in the circulation, factors from the lung are hypothesized to exert
detrimental action on the vascular endothelium via cell surface receptors. CD36
has been previously identified as a putative receptor that mediates endothelial
cell dysfunction cause by inhalation ozone-induced circulating factors110.
Furthermore, Rao and colleagues113 found that CD36 was central to the
progression of atherosclerosis cause by inhaled ambient particulate matter in
apolipoprotein E-deficient mice, an effect plausibly mediated by enhanced
generation and phagocytic uptake of oxidized cholesterol by macrophages.
Activation of CD36 has been linked to endothelial dysfunction, anti-angiogenesis
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and inflammation in other condition121,122, making this a compelling target to
investigate as a mediator of MWCNT-induced cerebrovascular outcomes.

1.13 Hypothesis and Specific Aims
This information allows me to form a hypothesis and subsequent specific
aims to test this hypothesis. I hypothesize that inhalation of multiwalled carbon
nanotubes will result in systemic inflammation and vascular dysfunction
via MMP-9 activation in the lungs.

1.13.1 Specific Aim 1
First, I will explore the dynamics of serum-based in vitro and ex vivo
assays to determine how serum bioactivity is altered by inhalation of
environmentall-relevant particles and gases. Specifically, we will examine resuspended road dust particles, mixtures of vehicular emissions (gases and
particles) and hardwood smoke emissions. Serum will be tested for its ability to
induce inflammatory responses in cultured endothelial cells and to reduce
vasorelaxation in myographic preparations.

1.13.2 Specific Aim 2
My second specific aim will look at the ability of MWCNT exposure to
activate the endothelium and decrease NO bioavailability via loss of eNOS
activation. This aim will utilize both in vitro and ex vivo approaches. In vitro
approaches will center on MWCNT exposed serum’s ability to adversely affect
NO bioavailability as measured by electron paramagnetic resonance. This will be
followed by an acellular assay to determine if the exposed serum has any ability
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to scavenge NO. Ex vivo approaches will look at serum from MWCNT exposed
mice to affect eNOS mediated relaxation in isolated mouse aorta. CD 36 null
vessels will be used in the same manner to determine the role of the scavenger
receptor and its interaction will eNOS. Lastly, MMP-9 deficient mice will be
treated with MWCNT to test the role of MMP9 in generating the bioactive
circulating factors.

1.13.3 Specific Aim 3
My third aim will detail the ability of MWCNT exposure to elicit systemic
inflammation, with a special focus on activation of endothelial cells that
compromise the blood brain barrier, a specialized structure that controls the
transport of molecules into and out of the brain. This aim will utilize both in vivo
and in vitro approaches. In vivo analysis will focus on BBB permeability, proinflammatory cytokine expression in the brain, and immunohistochemistry to
identify astrocyte and microglial activation following MWCNT exposure. In vitro
analysis will focus on serum from MWCNT exposed mice ability to induce
expression of pro-inflammatory mediators at the gene and protein level, as well
as its ability to negatively affect cell mobility in a “wound healing” assay. Primary
cerebrovascular endothelial cells will be used of the in vitro asays. Lastly
mechanisms of neuroinflammation will be investigated by utilizing fasudil, a Rho
kinase inhibitor, to modulate BBB permeability. CD36-/- mice will be used to
determine the role of the scavenger receptor in inducing BBB permeability and
neuroinflammation. We will further examine the role of MMP9 in driving these
effects using transgenic mouse models. (Figure 1.3)
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Figure 1.3: Schematic Representation of Specific Aims.
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2.1 ABSTRACT
Chronic cardiovascular disease is associated with air pollution exposure in
epidemiology and toxicology studies. Inhaled toxicants can induce changes in
serum bioactivity that impact endothelial inflammatory gene expression in vitro
and impair vasorelaxation ex vivo, which are common precursors to
atherosclerosis.

Comparisons between single pollutants and common

combustion mixtures, in terms of driving such serum inflammatory and
vasoactive effects, have not been characterized. Healthy C57BL/6 mice were
exposed to a single 6h period of contrasting pollutant atmospheres: road dust,
mixed vehicle emissions (MVE; a combination of gasoline and diesel engine
emissions) particulate matter (MVE-PM), mixed vehicle emissions gases (MVEG), road dust plus ozone, road dust plus MVE, and hardwood smoke. Serum
obtained from mice 24h after these exposures was used as a stimulus to assess
inflammatory

potential

in

two

assays:

incubated

with

primary

murine

cerebrovascular endothelial cells for 4h to measure inflammatory gene
expression, or applied to naïve aortic rings in an ex vivo myographic preparation.
Road dust and wood smoke exposures were most potent at inducing
inflammatory gene expression, while MVE atmospheres and wood smoke were
most potent at impairing vasorelaxation to acetylcholine.

Responses are

consistent with recent reports on MVE toxicity, but reveal novel serum bioactivity
related to wood smoke and road dust.

These studies suggest that the

compositional changes in serum and resultant bioactivity following inhalation
exposure to pollutants may be highly dependent on the composition of mixtures.
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2.2 INTRODUCTION
Air pollution exposure is associated with adverse cardiovascular
outcomes123,124 despite limited direct systemic absorption or translocation of
pollutant components into the body

38,125,126

. In recent studies, serum or plasma

obtained after pollutant exposures has been shown to possess a pathologic
bioactivity capable of inducing inflammation, arresting growth, and impairing
vasodilation in cell culture or isolated organ experiments

109,110,127

.

Because

these studies employed such varied pollutants as diesel exhaust, nitrogen
dioxide, ozone, and nickel nanoparticles, it is difficult to gauge the relative
potency of these pollutants in driving a serum-borne bioactivity without head-tohead experiments.
Ambient air pollution is comprised of a complex and dynamic mixture of
gaseous and particulate substances that may all have varying cardiovascular
impact

128

. Emissions arising from traffic have been shown to have a focused

impact on cardiovascular outcomes in epidemiological studies

129,130

exhaust inhalation impairs vasoreactivity in healthy individuals

131

.

and diesel
However,

overall ambient air pollution remains an important contributor to chronic
cardiovascular disease and numerous source apportionment studies have drawn
different conclusions regarding the relative potency of ambient airshed
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constituents. A recent examination of cardiovascular hospital admissions in the
Northeast U.S. implicated road dust contributions, moreso than motor vehicles,
oil combustion, sea salt, or regional sources, as being a principal driver

132

.

However, earlier studies suggested a stronger association with mobile source
emissions and cardiovascular hospital admissions

129

.

The current lack of

understanding of the pathogenesis on cardiovascular health impacts of inhaled
materials substantially impedes our ability to derive congruous conclusions from
large-scale population studies.
The overarching hypothesis of the present work is that inhaled materials
lead to compositional changes in the blood that are then conveyed by the
circulation to vulnerable sites, such as atherosclerotic regions of the coronary or
cerebrovascular arterial beds, and there the bioactive serum may promote
inflammatory responses or impair vasodilation.

Given the myriad potential

compositional changes of the circulation, the present study utilizes two related
functional outcomes, inflammatory response and vasorelaxation, under an
endothelial cell biosensor assay paradigm. Using healthy mice exposed to a
battery of varied complex pollutant atmospheres, we examined the relative
impact of serum changes on inflammatory and vasoactive impairments.

2.3 METHODS
2.3.1 Animals:
Male C57BL/6 (Jackson Laboratories) and Apolipoprotein E-null (ApoE-/-;
Taconic Laboratories) mice were obtained at 6-8 weeks of age and quarantined
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for 14 days prior to exposures. Mice were housed in standard shoebox caging
under AAALAC-approved conditions for temperature and humidity, with food and
water available ad libitum, except during exposures. Following exposures, mice
were euthanized by humane means (pentobarbital) and tissues collected. For
myograph experiments, male C57BL/6 mice were also used as donors for aortic
rings. Donor mice were euthanized via exsanguination while under anesthesia
(isoflurane; concentration 1.5-2%). All procedures were approved by both the
University of New Mexico and the Lovelace Respiratory Research Institute
animal care and use committees.

2.3.2 Exposures:
All exposures with C57BL/6 mice were conducted for a single 6h period,
and serum was obtained 18h following the cessation of exposures (N=6 per
group). All exposure systems have been rigorously characterized in terms of
chemical composition and each is described in brief, below. Exposures were
conducted in 1 or 2 m3 whole-body rodent inhalation chambers (Lab Products,
Inc., Maywood, NJ) that were ventilated with exposure atmospheres at ~500 lpm,
for a residence time of approximately 4 min. The chambers contain sampling
ports above each cage unit to facilitate characterizing spatial homogeneity of
exposures and to provide multiple sample locations for exposure characterization
(Figure 1). During the exposures, concentrations of particulate matter were
measured by gravimetric analysis of filter samples three times during each
exposure. For each exposure condition, a matched cohort of mice exposed to
filtered air (FA) was included as a sham control group.
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Figure 2.1: General schematic for inhalational exposures.

Road dust was obtained from roadway surfaces on residential streets and
urban arterials in Phoenix and Tucson, AZ

128

. Material was vacuumed from

street surfaces with a commercially- available, standardized, low-volume surface
sampler (CS3, Inc., Sandpoint, ID). The sampler excluded particulate material
>10 microns during collection. Particulate samples were subsequently sieved on
an orbital shaker and the finest fraction (<38 µm bulk material diameter) was
retained. Aerosol generation was conducted with a Wright-dust feeder that was
40

coupled to a PM2.5 cyclone on the effluent stream to remove particles >2.5
microns. This size selective cut was used to ensure the material was in the
respirable range for a rodent.
Ozone was generated using a Sander Ozonisator (Model IV, Sander
Company, West Germany), diluted to 0.3 ppm, and monitored with a Teledyne
Ozone Analyzer (Model 465L, Teledyne, San Diego, California).
Mixed vehicle emissions (MVE) were generated by combining exhausts
from a diesel generator (single-cylinder, 5500-watt, Yanmar diesel-engine
generator

133

using Number 2 Diesel Certification Fuel) pulling a constant 90%

load during operation with a gasoline engine (1996 General Motors 4.3 L V6
gasoline engine) connected to an eddy current dynamometer

134

. The ratio of

diesel PM to gasoline engine PM was approximately 5:1, but gasoline contributed
greater ratios of gaseous components. Oxides of nitrogen (NOx) and carbon
monoxide (CO) concentrations were monitored and recorded at approximately
30–60 minute intervals throughout the exposures.
Woodsmoke was generated by a PineRidge wood-burning stove burning a
supply of solid oak logs.
National Particulate Component Toxicity Initiative Study: Additionally,
serum was available from previous studies using 50-day exposures in ApoE-/mice. In the present manuscript, serum from road dust, road dust with MVE
gases, and MVE gases was used in in vitro assays, described below. These
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exposures are described in detail elsewhere

128

and are the basis for exposures

above.

2.3.3 Serum Inflammatory Potential:
Cell culture of murine cerebrovascular endothelial cells and isolation of
RNA was performed similarly to previously described methods. Briefly, murine
cerebrovascular endothelial cells (mCECs) were obtained from a commercial
vendor (Cell Biologics). Serum from each subject was added to individual wells of
a 24-well plate at a ratio of 1:40 (2.5%) with complete culture media and
incubated for 4h at 37°C. Following incubation, cell supernatants were collected
and mCECs were washed with PBS, lysed and immediately cell lysates were
pooled and collected for RNA purification. Total RNA was isolated using RNeasy
Mini Prep Kits (Qiagen) and RNA was reverse-transcribed using High-Capacity
cDNA Reverse Transcription Kits (Applied Biosystems) prior to quantitative realtime PCR (qPCR) assessment of endothelial adhesion markers. Amplification of
target message was performed in Taqman® universal master mix following
manufacturer’s recommended conditions with Taqman® Gene expression
assays for inflammatory markers included the arachidonic acid metabolizing
enzyme cyclooxygenase-2 (COX2 aka PTGS2), adhesion molecules (ICAM1,
VCAM1), and cytokines (IL-6, CXCL1, CCL2, and CCL5) with endogenous
TATA-box binding protein (TBP) as the housekeeping gene.
expression was analyzed by the 2-ΔΔCT method
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using a relative amount of

mRNA for each sample normalized to TATA-box binding protein.

42

Relative gene

2.3.4 Ex Vivo Serum Effects on Vasorelaxation:
Serum from exposed mice was applied to aortic rings from naïve mice to
assess the impact on acetylcholine-mediated relaxation, similar to that previously
described 110. Briefly, thoracic aortas were isolated from naïve C57BL/6 mice and
cleaned of connective tissue. Ring segments of aorta (2-3 mm length) were then
mounted in a myograph system (610 M; DMT, Inc, Atlanta, USA) and submerged
in physiological salt solution (composition in mM: 119.0 NaCl, 25.0 NaHCO3, 5.5
glucose, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 0.027 ethylenediaminetetraacetic
acid, 2.5 CaCl2) bubbled at 37ºC with 21%O2-5%CO2-balance N2, and left to
equilibrate at 2 g of tension for approximately 30 min. Tension was gradually
applied over 10 min to an optimal passive tension of 10 mN. Vessel viability was
confirmed by a contractile response on addition of high potassium PSS (KPSS in
mM: 64.9 NaCl, 25.0 NaHCO3, 5.5 glucose, 58.9 KCl, 1.2 MgSO4, 1.2 KH2PO4,
0.027 ethylenediaminetetraacetic acid, 2.5 CaCl2), repeated twice.
After a 30-min equilibration period, vessels were incubated with 1% serum
obtained from WT mice following exposure to FA or other pollutant atmosphere
(N=5-7 per group). To generate a control relaxation curve for the various
atmospheres, serum from 1-2 mice per control group were used and the data
from these ACh-response curves were pooled (n=7). This allowed for control
data to be collected in parallel with all other atmospheres. Addition of serum to
the myography bath induced contraction of aortic rings and cumulative
concentration-response curves to ACh (10-9-10-4) were performed after response
to serum had stabilized (approx. 20 min). Data were acquired by a MacLab/4e
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analogue-digital convertor displayed through Chart™ software (AD Instruments,
USA).

Relaxation data are expressed as a percentage of serum-induced

contraction, with baseline tension subtracted.

2.3.5 Statistics:
Serum effects on gene expression were compared by an unpaired
Student’s t-test with each exposure linked to the simultaneously-conducted
filtered air control group. Subchronic studies in ApoE-/- mice were compared with
an ANOVA with Dunnett’s Multiple Comparison Test. Myographic studies were
compared with a two-way analysis of variance considering exposure and
acetylcholine concentration as the two factors, and post-hoc comparisons at
specific acetylcholine concentrations were conducted using a Fisher’s Least
Significant Difference test (GraphPad Prism, v 6.0).

To generate a control

relaxation curve for the various atmospheres, serum from 1-2 mice per control
group were used and the data from these ACh-response curves were pooled
(n=7). Other comparisons were conducted with a standard one-way analysis of
variance.

2.4 RESULTS
2.4.1 Exposure Generation:
Particulate matter and gas concentrations for each exposure atmosphere,
both target and measured values, are shown in Table 1. Filtration of the MVE
atmosphere effectively removed approximately 96% of particulate mass
compared to the pre-filtration atmosphere. In contrast, denuding the MVE
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atmosphere to reduce the gaseous fraction effectively removed 84% of NOx and
85% of CO compared to the pre-denuded atmosphere.

EXPOSURE
Road Dust
Road Dust + MVE

PM (µg/m3)
Target
Actual
300
349
200+100 342

MVE Gases

0

13

MVE PM

300

328

Road Dust +
0.33 ppm Ozone
Woodsmoke
MVE (for ApoE-/mice)

300

344

300
300

380
349

NOx (ppm)
Pre
Post
10.2
(2.5)
28.6
25.6
(5.1)
(6.3)
24.6
4.0
(8.0)
(1.2)
-

CO (100 ppm)
Pre
Post
25.6
(8.2)
66.2
58.5
(24.4)
(26.6)
54.6
8.0 (3.1)
(9.3)
-

17.8
(4.8)

32.4
(8.2)

-

-

Table 2.1. Concentrations of major atmosphere components, PM, NOx, and CO in the 7
test atmospheres.
For Nox and CO, values for “pre” and “post” indicate values upstream and downstream of the
denuder or filter, when in use. Values are given and mean and (SD).

2.4.2 In Vitro Serum Inflammatory Potential:
We analyzed a panel of inflammatory markers expressed in cultured
endothelial cells at the mRNA level, as an indicator of the cumulative
inflammatory potential of serum from exposed mice.

Serum obtained from

C57BL/6 mice exposed for a single 6 h period to Road Dust was able to potently
induce several inflammatory genes, namely cytokines IL-6, CXCL1, CCL2, and
CCL5 (Figure 2.2). Interestingly, serum from mice exposed to Road Dust + MVE
did not display this inflammatory induction on endothelial cells.

Consistent

responses were observed with serum from Road Dust + O3, however, with
endothelial transcription of CCL2, ICAM-1, and VCAM-1 being significantly
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elevated. Serum from mice exposed to MVE PM or MVE gases failed to elicit
any induction of the inflammatory genes that were assessed in cultured mCECs.
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Figure 2.2: Serum-induced endothelial cell gene expression in an in vitro assessment of
inflammatory potential.
Serum was obtained 24h after C57BL/6 mice were exposed for 6h to one of 6 atmospheres.
Each exposure group (N=6) had a unique filtered air control group (N=6). Results for each gene
are compared by a Student’s t-test, with asterisks indicating p<0.05.

Given the divergent responses between Road Dust and Road Dust +
MVE, we retrieved banked serum from previous studies on these pollutant
atmospheres128. This previous research involved the exposure of ApoE-/- mice to
Road Dust (the same source material and concentration used in the single day
exposure), Road Dust + MVE gases, and MVE gases, albeit for a subchronic
study design (6 h/d x 50d) 128. In co-incubations with mCECs, we also noted that
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serum obtained from Road Dust had a substantial impact on expression of
CXCL1, CCL2, and CCL5 (Figure 2.3). Combined with the gaseous fraction of
MVE, however, Road Dust failed to confer such inflammatory potential on the
serum, consistent with the 1-d studies (Figure 2.3). The MVE gas fraction alone
was similarly ineffective at increasing serum inflammatory potential. These data
suggest that certain gases in the complex mixture may act to inhibit inflammatory
responses of endothelial cells or the formation of inflammatory intermediates in
the serum.
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Figure 2.3: Serum-induced endothelial cell gene expression in an in vitro assessment of
inflammatory potential.
-/-

Serum was obtained 24h after ApoE mice were exposed for 6h/d x 50d to one of 3
atmospheres. Exposure groups (N=6 per group) were conducted in parallel with a single filtered
air control group (N=6). Results for each gene are compared by an ANOVA with Dunnett’s
Multiple Comparison Test. Asterisks indicate significant difference from control (*p<0.05;
**p<0.01).
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2.4.3 Serum from Exposed Mice Impacts on Vasorelaxation:
In contrast to inflammatory markers in cultured cells, serum from Road
Dust and Road Dust + O3 exposure mice had no apparent effect on
vasorelaxation in co-incubated aortic rings from naïve mice, compared to serum
from control (filtered air exposed) mice (Figure 2.4). However, all atmospheres
that contained complex emissions gases induced changes in serum that impaired
relaxation ex vivo. Additionally, PM from MVE, with copollutant gases removed
by denudation, was also able to reduce vasorelaxation responses to
acetylcholine. In terms of magnitude of response, the atmospheres MVE PM,
MVE Gases, wood smoke, and Road Dust +MVE could not be statistically
differentiated, with all inducing a 20-40% reduction to the maximal effect in FA
controls (Supplemental Fig 1). Additionally, all serum applications in the ex vivo
bath led to some degree of contraction from the baseline tension. Serum from
mice exposed to MVE PM or Road Dust + MVE induced the greatest contraction,
relative to FA controls (Figure 2.5), even at a substantial dilution, suggesting the
induction of pro-constrictive factors in the serum.
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Figure 2.4: Serum-induced impairments of vasorelaxation response to acetylcholine.
Results are compared by a two-factor ANOVA, considering exposure and acetylcholine
concentration as factors, with a Fisher’s Least Significant Difference test to compare specific
concentrations (GraphPad Prism, v 6.0). Asterisks indicate significant difference from control
(*p<0.05; **p<0.01, ***p<0.001).
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Figure 2.5: Serum-induced contraction in aortic rings.

Upon incubation with serum in the tissue bath, aortic rings developed spontaneous tone
relative to baseline that was comparable to that induced by KPSS. Asterisk indicates
significant difference from filtered air (FA) controls by ANOVA with an Uncorrected
Fisher’s Least Significant Difference test (P<0.05).

2.5 DISCUSSION
This study represents the first head-to-head comparison of inflammatory
potential and vasoactivity of serum resulting from various complex pollutant
exposures.

Several conclusions can be inferred from the outcomes. First, a

single day of exposure to these complex pollutant atmospheres in healthy
C57BL/6 mice readily drove a varied bioactivity that was carried by the serum.
Second, impairment of acetylcholine-induced vasorelaxation was not induced by
the same serum modifications that caused inflammation, as there was very little
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overlap in these outcomes across different atmospheres. This suggests that
specific serum compositional modifications may result from exposures to varied
pollutants, resulting in divergent biological impacts. The exception to this was
wood smoke exposure, which caused serum bioactivity that induced both
inflammatory and vasoactivity changes. Specific differences in the responses to
the atmospheres belie simplistic interpretation, but the overall bioactivity of the
serum is consistent with recent studies in mice and humans 109,110,127.
Divergent inflammatory effects from the three atmospheres containing
Road Dust are the most difficult to explain. The potent induction of inflammatory
chemokine transcripts by serum from Road Dust exposures was confirmed with
serum obtained from a sensitive model (ApoE-/- mice) exposed subchronically
(50d). While it is not clear form our study design whether the serum inflammatory
potential was increased by the repeated exposure or the hypercholesterolemic
model, the end result is coherent with the single day exposures. Additionally, the
lack of effect of combined RD and MVE or MVE gases in both models helps to
strengthen this unexpected finding. Speculatively, one or more components of
the combustion mixture could diminish the pulmonary interactions with the Road
Dust particles, such as anti-inflammatory gases like carbon monoxide

136

. In the

analysis of aortic pathological outcomes of the 50d Road Dust and MVE gas
exposures, we did not see protective effects, but the deleterious interactions
seen between MVE gases and other particles (MVE PM, sulfate PM and nitrate
PM) were invariably more pronounced than for Road Dust 128.
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Serum-induced impairments in vasorelaxation were evident in 4 of the 6
atmospheres tested. Road Dust alone failed to induce any changes, along with
Road Dust + O3. Serum obtained from mice exposed to O3 at higher levels (1
ppm) induced substantial diminution of vasorelaxation to acetylcholine in a
similar model, a response that did not appear to be dependent on lung
inflammation but was dependent on vascular CD36

110

. MVE PM, however, did

lead to the induction of bioactivity in serum that impaired vascular responses to
acetylcholine. Both MVE PM and MVE gases caused similar effects on serum in
a 50d study, but the relative potency was reversed, with MVE PM eliciting the
strongest loss of relaxation

137

. The substitution of a portion of MVE PM with

Road Dust PM in the whole MVE led to similar changes in serum bioactivity as
MVE PM alone. As recently postulated

128

, combining combustion-source gases

from fresh emissions with aged or secondary particles may enhance particle
toxicity. Furthermore, we have confirmed the clinical relevance of diesel-induced
serum bioactivity in human studies, showing not only induction of genes used in
the present study (IL-8, ICAM-1, VCAM-1), but also a more complete microarray
analysis of the endothelial cell response to plasma post-exposure (Channell et
al., 2012; Schisler et al., 2015). The microarray analysis noted induction of more
global inflammatory pathways in the endothelial cells treated with plasma postdiesel exposure, as well as induction of transcription factors previously
unassociated with air pollution effects, including FOXO4, FOXF2, and TCF3
(Schisler et al., 2015).
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Wood smoke findings are relatively novel and few studies have addressed
cardiovascular health effects of biomass combustion. Epidemiological studies
related to wildfires are suggestive of a possible cardiovascular effect, but roughly
equal numbers of positive and negative findings reflect a high variability of
exposures associated with such sporadic natural events

132

. Forchhammer and

colleagues observed no adverse effects in exposed human subjects at up to 354
µg PM/m3 wood smoke for 3 hours

138

. Microvascular function assays were

conducted 6 h after and blood samples were taken at 0, 6, and 20 hours after
exposure for measures of oxidative stress and inflammation, with no obvious
changes detected. Unosson and colleagues reported increased arterial stiffness
in response to a comparable wood smoke exposure in health human subjects139,
although in a follow-up study in firefighters, wood smoke exposure did not
compromise vasodilatory capacity

140

.

Utilizing filtrations systems to reduce

indoor wood smoke PM levels in participating households in British Columbia,
however, significantly improved vascular hyperemic response along with a 30%
decrease in circulating C-reactive protein levels

141

. However, controlled wood

smoke exposures in mice have not resulted in substantial cardiovascular toxicity
142,143

. Thus, the current findings showing that serum contains some potentially

adverse bioactivity suggest that further research may be needed to identify
specific factors responsible, and possibly factors that confer vulnerability.
The value of utilizing serum from exposed mice to test the inflammatory
potential on endothelial cells lies in the rigor and pertinence of the inhalation
methodology. As opposed to treating endothelial cells in vitro with unjustifiably
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high concentrations of particulates – with no consideration of co-pollutants – the
present approach incorporates true inhalation exposures and then exposes
endothelial cells to factors that would definitely be in direct contact with the
endothelium in vivo. Furthermore, the treatments are at a highly dilute manner,
owing to the requisite conditions for cell culture and isolated organ techniques.
We do not propose what factor(s) may be responsible for these outcomes, as
thousands of biomolecules are present in the serum and the present study is
designed to assess the cumulative impact. Furthermore, the subsequent step of
extrapolating the present outcomes to whole animal pathophysiology is less
clear. We have recently shown that similar serum bioactivity exists in clinical
syndromes, such as coronary artery disease, and clinical trials with the
polyphenol resveratrol showed that reductions in serum inflammatory potential
could be elicited in otherwise healthy human subjects (Cung et al., 2015).
Quantitative links between the inflammatory potential in humans and laboratory
species, in addition to linkages between short-term endothelial responses and
chronic inflammatory diseases simply do not exist at present, owing to the
novelty of the approach.
Overall, the findings of the present study reveal a consistent pattern of
serum modifications following inhalation exposure to complex pollutants that lead
to altered bioactivity. Both outcomes assessed – inflammatory pathways and
impaired relaxation – are presumed to be part of a continuum of the early stages
leading to atherosclerosis

144

. It was somewhat surprising that there was not

more overlap between the pollutant atmospheres and serum-induced outcomes.
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The main gap in the present study is a lack of serum compositional
characterizations to examine potential candidate molecules to drive the varied
effects.

However, a thorough investigation, via proteomic or metabolomic

approaches, is likely to yield more candidates than can be adequately confirmed
in a single study. Future research will need to link complex compositional data
sets with functional assay outcomes such as were developed in the present
study to better delineate causal components.
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Figure 2.6 (Supplemental Figure 1): Acetylcholine response curves from Figure 2.4
overlaid to compare the relative magnitudes of impairment.
Atmospheres that caused any significant diminution of response (wood smoke, MVE PM, MVE
Gases, Road Dust + MVE) did not clearly separate, causing approximately the same level of loss
of the relaxation response to acetylcholine.
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3.1 ABSTRACT
Inhalation of multi-walled carbon nanotubes (MWCNT) causes systemic
effects including vascular inflammation, endothelial dysfunction, and acute phase
protein expression. MWCNTs translocate only minimally beyond the lungs, thus
cardiovascular effects thereof may be caused by generation of secondary
biomolecular factors from MWCNT-pulmonary interactions that spill over into the
systemic

circulation.

Therefore,

we

hypothesized

that

induced

matrix

metalloproteinase-9 (MMP-9) is a generator of factors that, in turn, drive vascular
effects through ligand-receptor interactions with the multiligand pattern
recognition receptor, CD36. To test this, wildtype (WT; C57BL/6) and MMP-9-/mice were exposed to varying doses (10 or 40 µg) of MWCNTs (MWCNT-7) via
oropharyngeal aspiration and serum was collected at 4 and 24 h post-exposure.
Cells treated with serum from MWCNT-7-exposed WT mice exhibited
significantly reduced NO generation, as measured by EPR, an effect that was
independent of NO scavenging. Serum from MWCNT-7-exposed WT mice
inhibited acetylcholine-mediated relaxation of aortic rings at both time points.
Absence of CD36 on the aortic rings abolished the serum-induced impairment of
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vasorelaxation. MWCNT-7 exposure induced MMP-9 protein levels in both
bronchoalveolar lavage and whole lung lysates.

Serum from MMP-9-/- mice

exposed to MWCNT did not diminish the magnitude of vasorelaxation in naïve
WT aortic rings, although a modest right shift of the acetylcholine dose-response
curve was observed in both MWCNT-7 dose groups relative to controls. In
conclusion, pulmonary exposure to MWCNT-7 leads to elevated MMP-9 levels
and MMP-9-dependent generation of circulating bioactivity that promotes
endothelial dysfunction and decreased NO bioavailability via interaction with
vascular CD36.
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3.2 INTRODUCTION
Pulmonary exposure to nanomaterials such as carbon nanotubes is
associated with the progression of cardiovascular disease 76. However, gaps
exist in our understanding of the pathways by which inhaled substances affect
the systemic vasculature, and this hinders our ability to predict risk and identify
potentially vulnerable subpopulations. Inhaled nanomaterials, such as multiwalled carbon nanotubes (MWCNTs), have limited ability to translocate into the
systemic circulation 125 and evidence for a direct interaction between
nanomaterials and vascular cells at relevant exposure concentrations is lacking.
Several studies have demonstrated more profound systemic vascular effects
arising from particle inhalation 145-147 as compared to gavage or even direct
intravenous injection 148,149, suggesting that secondary, circulating factors
induced by pulmonary responses to exposure contribute to adverse
cardiovascular effects.
Central to the development of cardiovascular disease is the activation of
the endothelium, characterized by the increased expression of adhesion
molecules, extravasation of leukocytes, and the loss of endothelial nitric oxide
synthase (eNOS) function 150. eNOS produces the diffusible molecule nitric oxide
(NO), which is anti-inflammatory, anti-coagulatory, and vasodilatory 20,21,151. In an
atherosclerotic state, eNOS becomes “uncoupled” leading to the loss of NO
bioavailability 19. Loss of NO enhances the pro-inflammatory environment that is
central to the progression of atherosclerosis. Mounting evidence suggests that
pattern recognition (e.g. TLR4) or scavenger receptors (e.g. CD36) play a
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prominent role in mediating endothelial activation 121,152. Lipid peroxidation
products present in the lung lining fluid following exposure to particulate matter
(PM) mediate systemic cellular inflammatory responses through Toll-like receptor
4, and such modified lipids have been shown to be present following exposure to
concentrated ambient particulate matter 114. CD36, a class B scavenger receptor,
recognizes many ligands and is widely expressed on the surface of multiple cell
types, including macrophages and endothelial cells 153,154. CD36 is involved in
atherosclerosis and inflammation 111 and is required for the endothelial
dysfunction induced by inhalation to the reactive gas ozone 110.
One potential source of circulating ligands that interact with pattern
recognition receptors following inhalation exposure is activation of matrix
metalloproteinases (MMPs) in the lung 155. MMPs have been shown to be
involved in a wide range of process including development, wound healing, and
host defense 156. MMP-9, an MMP that binds collagen based substrates, has
been shown to be unregulated and activated following exposure to PM and PMcontaining combustion mixtures 112,115,155. Erdely and colleagues reported
increased gene expression of MMP-9 in the lung, as well as an increase in
circulating MMP-9 as a result of pulmonary MWCNT-7 exposure 75. The
pathophysiological relevance of MMP9 activation following pulmonary exposure
to nanomaterials remains unknown.
Currently, no studies exist investigating the potential links between
vascular dysfunction, MMPs, CD36, and nanomaterial exposure. We
hypothesized that MWCNT-7 exposure activates MMPs in the lung, leading to
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the generation of circulating ligands that may directly impact vascular function
through the CD36 receptor. To test this hypothesis, we applied an innovative ex
vivo methodology for assessing potential cumulative effects of circulating
mediators on vascular function. In this study, we demonstrated that MWCNT-7
exposure induces the generation of circulating bioactive factors that diminish
stimulated NO production, impair vasorelaxation, and are not linearly associated
with MWCNT-7 dose.

3.3 MATERIALS AND METHODS
3.3.1 Animals
Specific pathogen-free, male C57BL/6J and MMP-9-/- (B6.FVB(Cg)Mmp9tm1Tvu/J) mice from Jackson Laboratory (Bar Harbor, ME) and CD36-/mice on a C57BL/6 background, bred in-house, were used in this study.
C57BL/6J and MMP9-/- mice for exposures were housed in the AAALACapproved NIOSH Animal Facility, while naïve mice (C57BL/6J and CD36-/-)
donating aortas were housed in AAALAC-approved facilities at the University of
New Mexico. All mice were provided food and tap water ad libitum in ventilated
cages in a controlled humidity and temperature environment with a 12 hr
light/dark cycle. Animal care and use procedures were conducted in accordance
with the “PHS Policy on Humane Care and Use of Laboratory Animals” and the
“Guide for the Care and Use of Laboratory Animals” (NIH publication 86-23,
1996). These procedures were approved by the respective Institutional Animal
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Care and Use Committees of the National Institute for Occupational Safety and
Health and the University of New Mexico.
Mice, 8 weeks of age, were treated via oropharyngeal aspiration with
MWCNT (MWNCT-7 / Mitsui-7) at 0 µg, 10 µg, or 40 µg (n=12 for each group
was needed to generate enough serum for all tests). The MWCNT were prepared
in a physiologic dosing media (DM) for the vehicle that consisted of mouse serum
albumin (0.6 mg/ml) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (10 µg/ml)
in PBS. The MWCNT used in this study, MWCNT-7, have been extensively
characterized previously 72. Mice were euthanized at 4 and 24 h following
pulmonary exposure. Serum was collected and the left lung lobe was ligated and
removed to preserve for MMP-9 protein determinations. Bronchoalveolar lavage
was performed on the right lung lobes and the first lavage supernatant was
assessed for lactate dehydrogenase activity, albumin concentration, and MMP9
levels.

3.4 Fractionation and Mass Spectrometry
Serum was first processed through a 0.1 µm Ultrafree-MC filtration unit
(EMDMillipore, Billerica, MA) per manufacturer instructions. The clarified serum
(100 µL) was then processed through a pre-cleaned Amicon Ultra-0.5 centrifugal
filter with Ultracel-30 membrane (EMDMillipore) per manufacturer instructions at
10°C. Filtered sera (n = 5 per 0, 10, 40 µg MWCNT-7 groups) were prepared for
liquid chromatography - tandem mass spectrometry (LC/MSMS). Samples (32
µL) were acidified with 8 µL of 1% formic acid, with 4 µL loaded onto a Symmetry
C18 reversed-phase trap column using a NanoAcquity UPLC (Waters, Milford,
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MA). Separation was performed with a 150 mm x 75 µm HSS T3 reversed-phase
capillary column at 55°C online with a nano-electrospray equipped Synapt G2
HDMS tandem mass spectrometer (Waters). Separation and data-independent
mass spectrometric analysis with ion mobility was performed as described
previously 157,158 with the modifications that gradient elution was performed from
2% to 42% acetonitrile in water (formic-acid modified) and spectra were collected
between 200 and 1800 m/z, with a collision energy ramp from 32 to 52 eV. All
spectra were post-processed employing PLGS ion processing software (Waters).
Generated ion tables were clustered and aligned by retention time (+/- 1.0 min),
drift time (+/- 4 bins) and ion mass (MH+, +/- 12 ppm) using Isoquant software
(v1.6 beta) 159,160. Results were filtered to include only reproducible ion events
(observed in four or more biological replicates per group). Ion mass tables per
group were then evaluated and compared using histogram analysis with a
minimum size of 500 Da.

3.4.1 Cell Culture
Mouse cerebrovascular endothelial cells (mCECs) were obtained from a
commercial vendor (Cell Biologics) and maintained according to manufacturer’s
recommendations at 37° and 5% CO2 – 95 O2 with complete endothelial cell
medium supplemented with 10% Fetal Bovine Serum (FBS). All experiments
were performed between passages 3-8. Assays were batched by exposure to
enhance consistency and comparability across samples.
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3.4.2 Spin trapping of MCEC-generated NO using electron paramagnetic
resonance.
To test the generation of NO, serum from control or MWCNT-7-treated
mice (4h post) was added to the mCECs at a ratio of 1:9 (10%) with basal
endothelial cell medium. Electron paramagnetic resonance (EPR) spectroscopy
was conducted according to previously described methods with some
modifications 161. Following serum treatment, mCECs were incubated with the
iron-chelate NO-spin trap Fe2+-di(N-methyl-D-glutaminedithiocarbamate)
(Fe2+(MGD)2; 1mM, final concentration) for 5 min. The iron-chelator
Fe2+(MGD)2 was freshly prepared by mixing a stock solution of ferrous sulfate
(FeSO4; 20 mM, dissolved in deionized water under N2) and an equal volume of
sodium N-methyl-D-glucamine dithiocarbamate (NaMGD; 100 mM, dissolved in
deionized water under N2) to give a molar ratio of 1:5, respectively, prior to each
experiment. Following the incubation period, the incubation medium (400 µL)
containing spin trapped NO was immediately transferred into custom-made gas
permeable Teflon tubing (Zeus Industries, Raritan, NJ), folded four times, and
inserted into a quartz EPR tube open at each end. The quartz EPR tube was
inserted within the cavity of a Bruker EleXsys E540 X-band EPR spectrometer
(Billerica, MA) operating at 9.8 GHz and 100 kHz field modulation and spectra
was recorded after spectrometer tuning at room temperature. The EPR spectrum
of spin trapped-NO were acquired from untreated mCECs with a scan time of
40s, and 10 scans were obtained and averaged to produce significant signal-tonoise ratio. EPR measurements from mCECs stimulated with 2 mM ATP to
induce NO release were performed under the same conditions. Instrument
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settings were as follows: magnetic field, 3440 G; scan range, 100 G; microwave
power, 21 mW; modulation frequency, 100 kHz; modulation amplitude, 1.0 G;
time constant, 20 ms. The EPR spectra were collected, stored, and manipulated
using the Bruker Software Xepr (Billerica, MA). NO levels were quantified and
peak-to-peak measurements were taken and expressed in relative units.
mCECs were grown to confluence on six-well plates and incubated with
10% MWCNT exposed serum for 4 h. Following serum treatment, mCECs were
incubated with Fe2+(MGD)2. Following application of the trap, a supernatant
sample was isolated and NO was measured to assess a baseline reading. NO
generation at baseline was negligible. Endothelial cells were subsequently
stimulated with 2 mM adenosine triphosphate (ATP) for 5 min, followed by
measurement of NO in a second supernatant sample.

3.4.3 Ex vivo vascular function using myography
Rings from the thoracic aorta were isolated and cleaned of connective
tissue. Segments of aorta (2 mm length) were mounted in a 4-chamber
myograph (610M; Danish Myo Technology A/S, Aarhus, Denmark). Vessels were
submerged in physiological saline solution (composition in millimolar: 119.0
NaCl, 25.0 NaHCO3, 5.5 glucose, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 0.025
EDTA, 2.5 CaCl2) bubbled at 37°C with 21% O2-5% CO2 balance N2 and left to
equilibrate for 30 min. Tension was applied in 2 mN stepwise increments over 30
min to an optimal passive tension of 9 mN. Preliminary experiments showed that
this tension produced optimal contraction and relaxation responses. Data from
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force transducers were processed by a MacLab/4e A-DI converter displayed
through LabChart software (AD Instruments).
Vessel viability was confirmed by a contractile response to the addition of
potassium containing physiological salt solution (KPSS in millimolar: 64.9 NaCl,
25.0 NaHCO3, 5.5 glucose, 58.9 KCl, 1.2 MgSO4, 1.2 KH2PO4, 0.025 EDTA,
2.5 CaCl2) repeated twice. Aortic rings isolated from naïve C57BL/6J or CD36null mice were mounted in a myograph and challenged twice with KPSS as
described above. After a 30-min equilibration period, vessels were incubated with
1% serum that was collected from mice exposed to dispersion media or MWCNT.
Because the addition of serum induced contraction of aortic rings, the cumulative
concentration-response curves to ACh (10-9-10-4) were acquired only after the
response to serum had stabilized.

3.4.4 Matrix Metalloproteinase Protein Levels in Lung
Lung lavage fluid and whole lung homogenates were assayed for MMP-2
and MMP-9 protein concentrations according to manufacturer’s instructions
(Boster, Pleasanton, CA).

3.4.5 Statistics
Myographic studies were compared with a two-way analysis of variance
considering exposure and acetylcholine concentration as the two factors, and
post-hoc comparisons at specific acetylcholine concentrations were conducted
using Fisher’s least significant difference testing (GraphPad Prism, v 6.0). Other
comparisons were conducted with a standard one-way analysis of variance.
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3.5 RESULTS
3.5.1 Multi-walled Carbon Nanotube Exposure results in Lung Cytotoxicity and
Permeability Changes
MWCNT-7 used in the present study have been previously characterized
72

. The average diameter was 49 nm with a mean length of 3.86 µm (geometric

standard deviation = 1.94; Figure 3.1A,B). Purity was >99% carbon. Exposure to
MWCNT-7 resulted in a dose-dependent increase in bronchoalveolar lavage
(BAL) lactate dehydrogenase (LDH) activity at the 4 h time point, which also
remained elevated at the 24 h time point. The 40 µg dose approximately doubled
LDH levels compared to controls at both time points, with the 10 µg dose
resulting in a 50% increase at both time points (Figure 3.1C). There was no
significant difference in albumin levels between groups at the 4 h time point;
however, both the 10 and 40 µg doses showed elevated albumin at the 24 h time
point when compared to controls. (Figure 3.1D).
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Figure 3.1
A,B. MWCNT-7 characterization by electron microscopy demonstrates the relative size and
adequacy of dispersion. C,D. Markers of injury in the lung lavage, LDH and albumin levels, were
increased following exposure (*p<0.05 vs DM by ANOVA, N=4-8 per group).
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3.5.2 Serum from MWCNT-Exposed Mice Decreases Endothelial NO Generation
In Vitro
The supernatant of serum-treated endothelial cells, when treated with ATP
and the NO spin-trap MGD, afforded a strong signal detectable by electron
paramagnetic resonance spectroscopy (Figure 3.2A). Baseline measurements of
unstimulated endothelial cells resulted in negligible amounts of NO production
between groups treated with exposed or control serum. In ATP-stimulated cells,
however, serum from MWCNT-7-exposed mice decreased NO bioavailability by
30% when compared to cells incubated with serum from DM control mice (Figure
3.2B).
These results led us to speculate that the serum from MWCNT-7-exposed
mice was able to directly affect eNOS or that the serum had the capacity to
“scavenge” produced NO. To address this question we applied an acellular
assay, bypassing the contribution of eNOS. MGD in iron-free media was
incubated with serum from MWCNT-exposed mice and the NO-donor spermine
NONOate (1M) as in previous studies with serum from ozone-exposed rodents
161

. However, serum from MWCNT-7-exposed mice had no effect on NO

bioavailability when compared to serum from control mice (Figure 3.2C). These
results suggested that serum from MWCNT-7-exposed mice diminishes eNOS
generation of NO, rather than NO bioavailability.
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Figure 3.2 Effects of serum from MWCNT-7-exposed mice on NO generation and
bioavailabilty.
A. Representative EPR spectra from endothelial cells incubated with control serum and serum
from MWCNT-7-exposed mice. B. Unstimulated endothelial cells exhibited minimal baseline
levels of detectable NO, which was not different when incubated with serum from DM (control) or
MWCNT-7-treated mice. However, when stimulated by ATP, endothelial cells incubated with
control serum demonstrated a significantly greater capacity to generate NO than cells treated with
serum from MWCNT-7-exposed mice (*p<0.05, N=3 per group). C. In an acellular assay, levels of
NO in iron-free media containing a known concentration of the NO donor, spermine NONOate,
were not different in the presence of serum from control or MWCNT-7-treated mice.

3.5.3 Serum from MWCNT-7-Exposed Mice Diminishes Vasorelaxation Ex Vivo
We next examined the role that MWCNT exposure might have in a
functional physiological system. We employed force-transduction myography with
an isolated aortic ring preparation to test the serum bioactivity. Serum from both
doses of MWCNT-7-exposed mice was able to significantly reduce acetylcholine
(ACh)-induced relaxation (Figure 3.3). Interestingly, the serum from 10 µgtreated mice collected 4 h post-exposure (Figure 3.3A) was more potent in terms
of inhibiting relaxation than was serum from 40 µg-treated mice, with the lower
dose reaching a maximum relaxation of only 13.6%, compared to 27.1% for the
higher dose and 49.4% for vehicle controls. This effect persisted at least 24 h
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post-exposure (Figure 3.3B), although more variability was noted. At 24 h post
exposure, serum from both low and high dose groups similarly inhibited
relaxation (26.9% and 28.5%, respectively), as compared to DM control serum.
In addition to ACh responses, we assessed whether the initial contraction
induced by serum treatment was similar between groups. Maximum vessel
constriction induced by serum was measured and normalized to a potassium
physiological saline solution (KPSS) response. There were no differences
between control and MWCNT doses at 4 h with complete serum (Figure 3A
right panel). However, serum obtained 24 h following MWCNT exposure did
induce a modest but significantly higher average constriction in the 40 µg group
(101% vs 80% for the low dose and 87% for the control; Figure 3.3B right
panel).
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Figure 3.3
A. Mouse serum obtained 4 h following MWCNT-7 treatment inhibited ACh-mediated
vasorelaxation in aortic rings from untreated (naïve) mice (left) and maximum vessel constriction
induced by serum (normalized to a KPSS response; right). Interestingly, the serum from low
dose-treated mice was more potent than serum from high dose-treated mice. Asterisks indicates
significant difference from control by two-way ANOVA with Tukey’s multiple comparison test
(*p<0.05, **P<0.001), dagger represents significant difference between the 10 and 40 µg doses
(†p<0.01; N=10 per group). B. Mouse serum obtained 24 h following MWCNT-7 treatment
inhibited ACh-mediated vasorelaxation in aortic rings from untreated (naïve) mice (left), however
the increased potency of the low dose exposure at 4 h was no longer observed. Maximum vessel
constriction induced by serum (normalized to a KPSS response) is also shown (right of each
relaxation curve). *Indicates significant difference from DM control by two-way ANOVA (*p<0.05,
**P<0.01; N=6−8 per group).
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3.5.4 Impact of Serum Fractionation on Vasorelaxation Responses
As an initial attempt to understand how serum bioactivity is driven by
altered biochemistry and to exclude a direct nanomaterial effect on
vasorelaxation, the serum was filtered to resolve smaller components (< 10 kDa)
for aortic ring treatments. Notably, the filtered serum allowed for greater overall
relaxation to ACh compared to whole serum, with an average relaxation of
77.39% for aortic rings incubated with filtered serum from DM-treated mice. In
the 4 h post-exposure samples, the <10 kDa biomolecules induced a prominent
anti-relaxation effect of serum from both doses of MWCNT-7-exposed mice,
although the specific enhanced potency of the 10 µg dose was no longer
observed (Figure 3.4A). The anti-relaxant effect of filtered serum components
from MWCNT-7-treated mice was largely abolished in the 24 h post-exposure
serum (Figure 4B), suggesting that the <10 kDa biomolecules may have
complexed with larger biomolecules or that larger biomolecules contribute to a
persistent effect. There were no differences in initial contraction between control
and MWCNT doses with 4 h filtered serum (removal of large, >10 kD proteins), or
with 24 h filtered serum (Figure 3.4A,B right panels, respectively).
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Figure 3.4
A. Mouse serum obtained 4 h following MWCNT-7 treatment was filtered to remove all larger
proteins, leaving only biomolecules < 10 kD. This filtered serum still inhibited ACh-mediated
vasorelaxation in aortic rings from untreated (naïve) mice. Asterisks indicate significant difference
from control by two-way ANOVA with Tukey’s multiple comparison test (*p<0.05, **p<0.01; N=5
per group). B. Filtered mouse serum obtained 24h following MWCNT-7 treatment did not affect
ACh-mediated vasorelaxation in aortic rings from untreated mice (N=5 per group). C. Mass
spectroscopic confirmation of numerous biomolecules ranging from 0.5 – 10 kDa remaining after
filtration. Individual peaks are collected into bins of the histogram and separated by dose group
for the 4 h post-treatment serum.

We employed LC/MSMS analysis to confirm that the serum fraction
consisted of biomolecules below 10 kDa (Figure 3.4C). Further, in comparing
the < 10 kDa serum fraction between treatment groups, we resolved differences
in the mass distribution among doses, consistent with the observations of
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nonlinear dose effects. Importantly, findings with filtered sera demonstrate that
bioactivity can be induced without any possibility of direct nanomaterial or
leukocyte interaction with the endothelium.

3.5.5 Vascular CD36 Mediates Endothelial Dysfunction Induced by Serum from
MWCNT-7-Exposed Mice
Aortas harvested from CD36-null mice were employed to determine if the
scavenger-receptor mediated effects of serum from MWCNT-7-exposed mice
were similar to previous findings with ozone and ambient PM 110,113. CD36-null
aortic relaxation in response to ACh was not impacted by serum from MWCNT-7exposed mice compared to serum from control mice (Figure 3.5). All three
groups reached an average maximum relaxation of ~50% (comparable to WT
vessels), with no discernible differences between the groups at either time point.
These results denote that the bioactive compounds in the serum following
MWCNT-7 exposure interact with CD36 to impair vasorelaxation.
Interestingly, however, serum from MWCNT-7-exposed mice applied to
CD36-/- vessels was observed to induce a greater average contraction of 100%
for the lower and 104% for the higher dose group at the 4 h mark compared to
aortic rings treated with control serum (87%; Figure 3.5A right panel). By 24 h,
the high dose group achieved a contraction of 101%, while the low dose was not
different from controls (Figure 3.5B right panel). These findings contrast with the
vasorelaxation data in that CD36 is not required to induce contraction due to
MWCNT-induced, serum-borne components.
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Figure 3.5
A. Mouse serum obtained 4 h following MWCNT-7 treatment had no effect on ACh-mediated
vasorelaxation in aortic rings from untreated CD36-null mice (N=5 per group). Significant
differences in the contractile response to the serum addition was noted for serum from MWCNT7-treated mice. Asterisks indicate significant difference from control by ANOVA with Dunnett’s
multiple comparison test (*p<0.05; n=5 per group). B. Filtered mouse serum obtained 24 h
following MWCNT-7 treatment had no effect on ACh-mediated vasorelaxation in aortic rings from
untreated CD36-null mice (N=4−5 per group). Significant differences in the contractile response
to the serum addition was noted for serum from the 40 µg MWCNT-7-treated mice. Asterisks
indicate significant difference from control by ANOVA with Dunnett’s multiple comparison test
(*p<0.05; n=5 per group).
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3.5.6 Serum from MMP-9 Deficient Mice Exhibits Reduced Vascular Bioactivity
after MWCNT-7 Exposure
Lastly, we investigated the potential role of MMP-9 as a source of
circulating ligands that are generated as a result of MWCNT-7 exposure. MMP-9
levels in WT mice treated with 10 and 40 µg MWCNT-7 were measured in the
lung and BAL at the protein level. MMP-9 was up regulated in the BAL at both 10
and 40 µg doses at 4h, and in the 40 µg dose at 24h (Figure 3.6A and B). MMP9 was also significantly upregulated in the lung lysate in the 40 µg dose at 24h
(Figure 3.6D). In contrast, MMP-2 protein levels were unchanged in the lung
lavage (Supplemental Figure 1).
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Figure 3.6: MMP-9 protein levels in bronchoalveolar lavage
(A,B) and whole lung lysates (C,D) from MWCNT-7-exposed mice. Asterisks indicate significant
difference from control by ANOVA with Dunnett’s multiple comparison test (*p<0.05; **p<0.01).

Building on the finding of MWCNT-7-induced pulmonary MMP-9
expression, MMP-9-/- mice were exposed to MWCNT-7 and the bioactivity of the
serum was tested for its ability to affect eNOS mediated vasorelaxation ex vivo.
Deficiency of MMP-9 (Figure 3.7) appeared fully protective relative to WT
outcomes (Figure 3.3). Pulmonary MWCNT-7 cytotoxicity, as measured by LDH
activity in the BALF, was similar between both WT and MMP9-/- mice (Figure
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3.7A). In both dose groups, WT vessels treated with serum from MMP-9-/- mice
achieved similar maximal relaxation compared with serum from DM-treated
MMP-9-/- mice, with an average response of ~55% (Figure 3.7B). However, the
dose-response curve revealed a significant right-shift in both dose groups relative
to DM-control serum, which suggests that some residual bioactivity may be
derived outside of MMP-9 activity. DM-control serum from the MMP-9-/- mice
was actually more permissive of vasorelaxation that WT serum in this ex vivo
assay, which further adds to the conjecture that MMP-9-derived degradation
products may impair vascular function (Supplemental Figure 2). Serummediated constriction (Figure 3.7C) was unaltered between exposure groups in
the MMP-9-/- animals. Collective maximal vasorelaxation outcomes for each
permutation at the 4-h time point clearly show that pulmonary MWCNT-7
exposure leads to bioactivity in the serum that impairs vasorelaxation in a
manner dependent on MMP-9 to generate the signal and CD36 to respond
(Supplemental Figure 3).
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A. MMP-9 mice exhibit similar degree of lung injury at 4 h post MWCNT-7 aspiration, as
measured by LDH from the BALF. Asterisks indicate significant difference from control by two-/way ANOVA with Tukey’s multiple comparison test (*p<0.01; **p<0.001). B. Serum from MMP-9
mice treated with 10 or 40 µg MWCNT-7 caused a modest right-shift effect on the concentration
response to ACh-mediated vasorelaxation in WT vessels, compared to serum from the DM
control mice, but did not reduce the overall magnitude of relaxation. Serum from the various
groups exhibited a consistent contractile effect on all aortas. Asterisks indicate significant
difference from control by two-way ANOVA with Tukey’s multiple comparison test (*p<0.05; n=5-6
per group).

3.6 DISCUSSION
In this study we provide functional evidence for a mechanism by which
MWCNT-7 exerts systemic endothelial dysfunction, which appears to be
indirectly mediated by serum-borne components. Pulmonary exposure to
MWCNT-7 led to the generation of bioactive factors in the serum that significantly
impaired vascular function ex vivo. Furthermore, the principal components of the
serum that confer abnormal vasorelaxation act through the vascular CD36
scavenger receptor and appear, at least acutely (4 h), to involve smaller
biomolecules (<10 kDa) released into circulation. The effects of MWCNT-781

induced serum biomolecules were not linearly associated with lung burden and
may reflect induction of different biological responses at different doses. Within
this study, we outline a plausible pathway by which ligands are derived from
MMP-9 activity in the lung, access the circulation and interact with vascular CD36
receptors to reduced vasorelaxation. This overarching paradigm provides
concrete mechanistic detail to theories of pulmonary “spillover” that explain the
pathogenesis of extrapulmonary effects of inhaled particulates 30,162, although the
biological complexity with potentially numerous metalloproteinases and pattern
recognition receptors involved must be considered. Importantly, the observed
vascular effects with serum from mice exposed to MWCNT-7 by a pulmonary
route resolves issues inherent to direct-application nanomaterial research with
cells or organs, offering an alternative and more anatomically sound approach to
study mechanisms underlying the extrapulmonary toxicity of inhaled particulates.
The mechanism by which serum from MWCNT-7-exposed mice exerts its
effects on vascular relaxation presumably involves impairment of eNOS and NO
generation. Inhalation of pollutants such as diesel emissions can lead to
uncoupling of eNOS and similar loss of dilatory function 163,164. Nurkiewicz et al.
found that TiO2 nanoparticles could directly scavenge NO 146, an effect that was
eliminated in the presence of antioxidants. We recently observed that serum from
ozone-exposed rats exhibited diminished serum levels of nitrites and nitrates,
and there was some evidence for increased nitrosothiol formation in serum,
suggesting that NO scavenging may occur 161. In the present study, however,
serum from MWCNT-7-exposed mice inhibited aortic vasorelaxation and
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endothelial cell generation of NO, but did not scavenge spermine NONOatedonated NO. The outcomes from cell culture and isolated aortic rings suggest
that a ligand-receptor interaction, and resultant intracellular signaling, mediated a
loss of eNOS activity and diminished vasorelaxation.
One potential mechanism to explain how serum from MWCNT-7-exposed
mice could impair eNOS is through the generation of CD36-interacting ligands
165

. Specific ligands to CD36 can adversely affect the lipid composition of

caveole, interfering with eNOS and potentially causing eNOS to become
uncoupled 121,166,167. The present data, combined with recent studies of ozoneinduced endothelial dysfunction 110, implicate an important role for CD36 in
mediating the loss of aortic vasorelaxation caused by serum from MWCNT-7treated mice. Notably, vessel relaxation in CD36-null aortas was more robust
than in WT aortas when treated with control serum. CD36 has been implicated as
a key inflammatory mediator in response to particulate matter exposure, an
important component of the macrophage response to oxidized lipids 113 and thus
may have broader implications for extrapulmonary effects than just endothelial
dysfunction.
We propose that an additional crucial step required for the induction of
eNOS-compromising bioactivity in serum from MWCNT-7-exposed mice involves
the activation of pulmonary MMP-9, leading to the generation of protein
fragments that can effect biological activity. MMP-9 plays a major role in the
degradation of extracellular matrix in a large spectrum of physiological and
pathophysiological process 118. MMP-9 is secreted by a wide number of cell
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types including neutrophils, macrophages and fibroblasts, creating the potential
for a large amount of MMP-9 to be generated as a result of lung injury.
Exposures to gasoline engine emissions in mice led to system-wide changes in
MMP-9 concentrations and activity, including induction within atherosclerotic
plaques 112. Furthermore, serum MMP-9 was found to be elevated in both mice
and humans exposed to diesel emissions 112. Pulmonary MMP-9 expression has
also been associated with vanadium 168, a vanadium-laden particulate 155 and
metal fume 169 exposures. Few studies have examined the pathophysiological
implications of MMP-9 activity in mediating pulmonary or extrapulmonary
outcomes of inhaled particulates. Our study found that despite comparable acute
(4-h) lung injury from MWCNT-7 exposure in WT and MMP-9-/- mice, MMP-9
deficiency resulted in diminished serum bioactivity after MWCNT-7 treatment
compared to WT. Interestingly, serum from MMP-9 deficient mice treated with
vehicle allowed for greater relaxation in aortic rings than did WT serum. MMP-9
has been shown to generate numerous vasoactive by-products from the
degradation of extracellular matrix proteins, such as angiostatin 170,171, tumstatin
172

, and β-dystroglycan 173. MMP-9 may therefore be responsible for the

generation of a number of vasoactive agents that help set baseline vascular tone.
Our study highlights the importance of pulmonary nanoparticle delivery in
driving systemic vascular effects and the doses used in this study, based on
numerous dosimetry analyses, represent an extreme but plausible scenario . It
should be appreciated that more pronounced effects were achieved at lower
depositions and a 1:100 dilution of serum from exposed mice nearly abolished
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vascular relaxation. Mice have a blood volume of approximately 2 mL, depending
on their body weight. Even if all of the MWCNT-7 left the lungs and stayed in the
bloodstream – a gross exaggeration – the MWCNT-7 concentration in serum
would be approximately 5 µg/mL, which would then be further diluted in the
vascular bath to a maximal theoretical (yet still improbably high) concentration of
50 ng/mL, a concentration far below what has been reported to induce
endothelial cell toxicity in vitro. The rationale for this extreme estimation of dose
lies in how pulmonary exposure to particulates leads to a clear systemic vascular
toxicity that cannot be reproduced with direct exposures of particles to the
vessels. Furthermore, filtration of serum which would exclude molecules >10
kDa and certainly any trace of MWCNT-7, did not entirely abrogate vascular
effects. Studies employing an oral gavage of carbon black were unable to induce
substantial vascular dysfunction in rats 148, and studies using an intravenous
injection of diesel exhaust particles, at similar concentrations to the current
MWCNT-7 doses, in mice were unable to induce vascular dysfunction 174. The
lack of biological effect in these alternate exposure routes serves to highlight the
importance of the pulmonary exposure in the pathogenesis of vascular
outcomes.
In conclusion, serum obtained from mice exposed to MWCNT-7 has the
capacity to impair vasorelaxation in naïve aortic rings ex vivo, an effect that
persisted at least 24 h after exposure. Notably, the low dose of 10 µg induced
even greater serum bioactivity at the 4-h time point than did the 40 µg dose.
Results from the present study further highlight the role of smaller, <10 kDa
85

biomolecules, in addition to larger species, which appear to be generated by
MMP-9 and may collectively act through the scavenger receptor CD36 to reduce
responsiveness to ACh. These data further support the concept that pulmonary
reactions lead to a spillover of secondary mediators from the lungs into the
systemic circulation. Future work will need to further elucidate, via fractionation
studies, which portions/components of the serum exhibit biological activity, as
well as peptide sequencing to provide further insight into the enzymatic origins of
the circulating peptides. Additionally, the use of serum from exposed mice in ex
vivo assays offers a novel, more anatomically sophisticated and even
translational approach for studying the systemic impact of inhaled substances.

86

BALF MMP2 (ng/ml)

600

DM
10µg
40µg

400

200

24
hr

4h
r

0

Figure 3.8 (Supplemental Figure 1): BALF MMP2 levels were not altered by MWCNT-7
exposure.
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Figure 3.9 (Supplemental Figure 2): Plotting acetylcholine relaxation curves for all DM, 10,
and 40 µg groups at 4 h.
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4.1 ABSTRACT
Multi-walled

carbon

nanotubes

(MWCNT)

are

highly

desired

by

manufacturers due to their mechanical properties, conductivity, and ability to
withstand a high degree of functionalization. Previous studies have shown
MWCNT exposure can cause cardiovascular effects such as systemic
inflammation and acute phase protein expression. However, the mechanism for
this, as well as potential inflammatory effects in other organs, such as the brain,
is not yet known. MWCNTs translocate only minimally from the lungs into the
systemic circulation. Therefore, their cardiovascular effects are most likely
mediated by generation of circulating factors that spill over into the systemic
circulation. It is possible that these factors can weaken blood brain barrier
integrity. To test this, mice were exposed to varying doses (10 or 40 µg) of
MWCNTs (Mitsui-7) via pharyngeal aspiration. Serum was collected at 4 and 24
h post-exposure, and applied to primary endothelial cells. Following exposure
mice experienced massive pulmonary inflammation, characterized by increased
gene expression of systemic pro-inflammatory cytokines. Systemic effects were
also observed, categorized by increased expression of acute phase liver
enzymes and immunohistochemical analysis of cerebellar and hippocampal
regions noted enhanced GFAP staining, indicative of astrocyte activation in
MWCNT-exposed mice. MWCNT exposure impaired blood brain barrier integrity,
as noted by fluorescein uptake, which was associated with increased gene
expression of IL-6 and CCL5 in the cortex and hippocampus. Pretreatment with
the rho kinase inhibitor fasudil was able to prevent brain fluorescein uptake and
neuroinflammation. Serum from MWCNT-7 exposed mice was able to induce
93

expression of adhesion molecules at both the gene and protein level in primary
murine cerebrovascular endothelial cells. Treatment of endothelial cells with
serum from MWCNT-7-exposed mice in a wound-healing assay resulted in
decreased cell motility and cytokinesis, also consistent with mRNA expression
patterns in microarray analysis. In conclusion, pulmonary exposure to MWCNT-7
alters circulating factors, which promotes endothelial cell inflammation,
decreases in cellular tight junctions, and activation of inflammatory cells in the
brain.

4.2 INTRODUCTION
Nanotechnology represents a broad interdisciplinary field of research and
industrial activity involving particles less than 100 nanometers (nm) in at least
one dimension. Nanoparticles are currently being incorporated into products in
diverse fields of manufacturing; however, as a result of their unique size,
nanoparticles exhibit novel physical, chemical, and biological effects in the
body46. A subset of nanomaterials, multi-walled carbon nanotubes (MWCNT),
has become increasingly desired due to the range of unique properties they
exhibit. These properties include its conductivity, tensile strength, and ability to
withstand a high degree of chemical manipulation175,176. As a result, hundreds of
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tons of MWCNTs are manufactured every year, increasing the likelihood of
occupational exposure in the manufacturing process177-179.
Multiple studies demonstrate that inhalation of MWCNTs induces lung
inflammation, indicated by infiltration of inflammatory cells from the periphery,
increased lung permeability, and fibrosis180. The literature provides evidence of
the systemic effects of MWCNTs75,181, but their ability to translocate into the
systemic circulation182 is minimal. The inability of MWCNTs to translocate from
the lung into the systemic circulation suggests a secondary mechanism through
which MWCNTs induce systemic toxicity. Previously our lab has shown that
pulmonary interactions can generate bioactive factors that spillover into the
systemic circulation and dissipate throughout the body109,110. One consequence
of these circulating factors is activation of the endothelium, characterized by the
expression of adhesion molecules, extravasation of leukocytes, and activation of
circulating inflammatory cells19. This combination of factors produces an
inflammatory state in the wall of the blood vessel, a process central to the
development of atherosclerosis. The nature and outcome of these effects is
dependent on the vascular bed where the inflammation occurs and can include
the aorta, mesentery, or cerebrovascular vessels.
Inflammation in the cerebrovascular vessels has been shown to increase
permeability of the blood brain barrier (BBB)183, a specialized structure
composed of astrocytes, pericytes and endothelial cells that acts as a barrier
between the brain and the rest of the body. Under normal conditions, the BBB
prevents passage of undesired molecules from the bloodstream into the central
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nervous system (CNS). However, under inflammatory conditions184, the tight
junctions between the endothelial cells can become destabilized resulting in a
leaky BBB and allowing peripheral inflammatory molecules to invade the CNS
and activate the brain’s resident immune cells, specifically microglia185 and
astrocytes.
Presently there are few studies investigating the link between inhaled
toxicants and neuroinflammation. Oppenheim and colleagues found that
inhalation of mixed vehicle emissions was able to induce BBB permeability, as
well as increase levels of inducible Nitric Oxide Synthase (iNOS) and IL-1β in the
parenchyma112. Additionally, ozone exposure in rats has been associated with
lipid peroxidation in the hippocampus186. To our knowledge, no studies currently
exist

exploring

the

role

of

engineered

nanomaterials

in

induction

of

neuroinflammation or BBB permeability.
We hypothesize that, following MWCNT exposure, neuroinflammation
arises due to increased BBB permeability caused by circulating factors. In this
study, we demonstrate that MWCNT exposure induces the generation of
circulating bioactive factors, leading to activation of the cerebrovasculature and
inflammatory cells, as well as increased BBB permeability.
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4.3 METHODS
4.3.1 Animals and Exposures
Specific pathogen-free, male C57BL/6J mice from Jackson Laboratory
(Bar Harbor, ME) were used in this study. All mice housed in the AAALACapproved NIOSH or University of New Mexico animal facility were provided food
and tap water ad libitum in ventilated cages in a controlled humidity and
temperature environment with a 12hr light/dark cycle. Animal care and use
procedures were conducted in accordance with the “PHS Policy on Humane
Care and Use of Laboratory Animals” and the “Guide for the Care and Use of
Laboratory Animals” (NIH publication 86-23, 1996). These procedures were
approved by the Institutional Animal Care and Use Committees of the University
of New Mexico and the National Institute for Occupational Safety and Health.
C57BL/6J mice, 8 weeks of age, were treated with MWCNT (MWCNT-7)
at 0, 10 µg, or 40 µg (n=12 for each group was needed to generate enough
serum for all tests). The MWCNT were prepared in a dispersion media (DM)
which served as the vehicle control. The DM consisted of mouse serum albumin
(0.6 mg/ml) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC; 10µ/ml).
The MWCNT used in this study, MWCNT-7, have been extensively characterized
previously 72,187. The average diameter was 49 nm with a length of 3.86 µm (GSD
1.94). Purity was >99% carbon. Mice were euthanized at 4 and 24 h following
pulmonary exposure. Serum was collected, and liver and the left lung lobe was
removed and frozen to determine changes in relative mRNA expression.

97

4.3.2 Blood Brain Barrier Permeability
Animals were injected with 2% fluorescein sodium salt (Sigma-Aldrich
F6377-100g, lot # MKBR1855V) 1 hour prior to sacrifice. Animals were
transcardially perfused with ice cold saline prior to removal and dissection of the
brain. Animals received Fasudil HCl (Selleckchem Catalog # S1573) formulated
at 20mg/kg 2 hours before sacrifice.

4.3.3 Fluorescein Quantification
Brains were weighed and homogenized in 500µl of 50% Trichloroacetic
acid. Following homogenization, supernatants were neutralized with 400µl of 5M
Sodium Hydroxide. Neutralized homogenate was spun down for 10 minutes at
10,000g to pellet the tissue. A 200µl sample was placed in a 96 well optical
bottom plate (Nagle Nunc International lot # 1019415) and read at 525/440nm in
a spectrofluorophotometer.

4.3.4 Immunohistochemistry
Four animals from each group were anesthetized with isoflurane and
transcardially perfused with saline followed by ice cold paraformaldehyde (PFA,
4% in PBS, pH 7.4). Brains were removed by decapitation, placed overnight in
4% PFA at 4°C, and then transferred to a 30% sucrose solution for ~48 hours at
4°C. Following cryoprotection, samples were rinsed with PBS and frozen in
optimal cutting temperature compound. 16 µm sagittal sections were collected on
a cryostat, dried, and stored at -20°C until use.
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Sections were blocked and permeabilized with a PBS solution containing
1% bovine serum albumin, 5% goat serum, and 0.2% Triton X-100 for two hours
at room temperature (RT). Primary antibodies were applied overnight at 4°C and
were either rabbit anti-glial fibrillary acidic protein (GFAP, 1:500, Dako, Z0334) to
label astrocytes, or rabbit anti-platelet endothelial cell adhesion molecule
(PECAM-1, 1:100, Santa Cruz Biotechnology, sc-1506-R) to visualize cerebral
blood vessels. The secondary antibody used was a donkey anti-rabbit Alexa
Fluor 555 (1:1000, Life Technologies, A31572) and was applied for 2 hours at
RT. All sections were stained with 4’,6-diamidino-2-phenylindole (DAPI, 1:1000,
Life Technologies, D3571) to label cell nuclei.
Imaging was performed by a blinded researcher on a Nikon TE2000
microscope with a nuance spectral camera (Quorum, model #N-MSI-FX) in the
University of New Mexico Fluorescence Microscopy Shared Resource Center.
Astrocytes were imaged in the hippocampus and cerebellar regions at 20X, and
GFAP intensity was quantified as a marker of astrocyte activation using ImageJ
software (NIH). In the cerebellum, three separate images were taken randomly
throughout lobule regions and GFAP intensity was averaged. Cerebellar
vasculature and fluorescein permeation were visualized using a 40X objective oil
immersion lens.

4.3.5 Tissue relative mRNA expression:
RNA was isolated from frozen lung (left lobe) and liver using the RNeasy
Mini Kit (Qiagen, Valencia, CA, USA). Evaluation of gene expression was
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determined by standard 96-well technology using the StepOne™ (Applied
Biosystems, Carlsbad, CA, USA) with pre-designed Assays-on-Demand™
TaqMan®

probes

and

primers

(Applied

Biosystems).

For

lung

Il6

(Mn00446190_m1), Ccl2 (Mn00441242_m1), and Cxcl2 (Mn00436450_m1) were
measured. For liver Mt1 (Mn00496660_g1), Mt2 (Mn00809556_s1), Saa1
(Mn00656927_g1), Hp (Mn00516884_m1), and Apcs (Mn00488099_g1) were
measured. Using 96 well plates, one µg of total RNA was reverse transcribed
using random hexamers (Applied Biosystems) and Superscript III (Invitrogen,
Carlsbad, CA). Nine µl of cDNA (1/10) was then used for gene expression
determination. Hypoxanthine-guanine phosphoribosyltransferase was used as an
internal reference. Relative gene expression was calculated using the
comparative threshold method (2-ΔΔCt) with vehicle-treated mice serving as the
reference group135.

4.3.6 Biometric analysis.
Sample: Labeled cRNA, from an input RNA of 375 ng, was prepared
according to the manufacturer’s protocol, using the illumina TotalPrep RNA
Amplification Kit (Ambion, Catalog #IL1791) for hybridization to the arrays. The
labeled cRNA samples were then assessed for quality and quantity. To ensure
consistency for the array hybridization, all cRNA samples for each time point
were quantified at the same time. The illumina RatRef-12 beadchip contains
22,523 probes and allows twelve samples to be interrogated in parallel. After a
20 h hybridization period at 58°C, the beadchips were scanned using an illumina
BeadStation 500G - BeadArray Reader (Illumina, Inc., San Diego, CA, USA).
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4.3.7 Microarray Analysis
Preparation of RNA. Total RNA was extracted and purified with Qiagen
RNeasy kit from each sample (Qiagen, Valencia, CA). The total RNA
concentrations were measured using the NanoDrop ND-1000 (ThermoScientific,
Wilmington, DE), and RNA integrity was checked using Agilent 2100Bioanalyzer
to assure sufficient quality before proceeding with microarray hybridization.
Microarray hybridization. Affymetrix GeneChip Mouse 430 2.0 arrays were
used for gene expression analysis. All procedures were performed according to
the manufactures instructions (Affymetrix, Santa Clara, CA). Briefly, 1.0µg of total
RNA was used to generate double-stranded complementary DNA (cDNA) using
an oligo dT-primer containing the T7 RNA polymerase promoter site and OneCycle Target Labeling Kit (Affymetrix). cDNA was purified via column
purifications using the GeneChip Sample Cleanup Module (Affymetrix), and
biotinylated complementary RNA (cRNA) was synthesized by in vitro
transcription using the GeneChip IVT Labeling Kit (Affymetrix). Biotin-labeled
cRNA was purified and absorbance measured at 260 nm to determine yield
(NanoDrop). Twenty micrograms of the labeled cRNA was fragmented and
hybridized to the Affymetrix GeneChip Mouse 430 2.0 arrays for 16 h at 45_C
following the Affymetrix protocol specific to the array type. Washing and staining
were performed on the Affymetrix Fluidics 450 station according to the antibody
amplification protocol (EukGE-Ws2v%;Fluidics Script). The GeneChips were
scanned using the Affymetrix GeneChip Scanner 3000.
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Statistical analysis procedures for whole microarray datasets have been
extensively described. Briefly, samples were imported into illumina® Beadstudio
3.0.19.0 and reference, hybridization control, stringency and negative control
genes were checked for proper chip detection. Beadarray expression data were
then exported with mean fluorescent intensity across like beads and bead
variance estimates into flat files for subsequent analysis. Illumina BeadArray
expression data were analyzed in Bioconductor using the ‘lumi’ and ‘limma’
packages. Gene lists containing group means of expression, p-values and
standard fold changes were utilized as input for subsequent bioinformatics
analysis. The Downstream Effects Analysis were generated through the use of
Ingenuity Pathway Analysis (Ingenuity® Systems, www.ingenuity.com). Whole
datasets containing gene identifiers and corresponding expression values were
uploaded into the application and a core analysis was done. Each identifier was
mapped to its corresponding object in Ingenuity's Knowledge Base. In this study
the following analysis criteria were utilized: log ratio of 0.5 and p<0.01. We have
previously shown that a 1.1-1.3 fold change offered a reasonable number of
molecules to evaluate responses (Erdely et al., 2014 – Type I interferon paper in
P&FT). The log ratio of 0.5 used in this study corresponds to a 1.4 fold change.
The differentially expressed genes were evaluated by the Downstream Effects
Analysis which enables a visualization of biological trends in the dataset and
predict the effect of gene expression changes on biological processes and
disease or on toxicological functions. The analysis identifies functions that are
expected to increase or decrease, given the observed gene expression changes.
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The Downstream Effects Analysis is based on expected causal effects between
genes and functions; the expected causal effects are derived from the literature
compiled in the Ingenuity® Knowledge Base.

4.3.8 Serum-treated MCECs.
For the volume limited MWCNT exposure samples, exposed serum was
added to the wells at a ratio of 1:9 (10%) with basal endothelial cell medium.
Exposed serum was added in a similar manner from dispersion media controls in
a 1:9 (10%). There was no FBS when exposed serum was mixed with basal
endothelial cell medium. All treatments were done for 4 hours.

4.3.9 Cell Culture.
Mouse Cerebrovascular Endothelial Cells (MCECs) were obtained from a
commercial vendor (Cell Biologics) and maintained according to manufactures
recommendations at 37° and 5% CO2 – 95% O2 with complete endothelial cell
medium supplemented with 10% Fetal Bovine Serum (FBS). All experiments
were performed between passages 3-8. Upon final plating, approximately 2*104
cells were added to each well of a 24-well plate (Beckon Dickinson) and grown to
confluence to mimic the cell-cell environment found in the vasculature. Cells
were serum starved for 12 hours prior to treatment with serum. Assays were
batched by exposure to enhance consistency and comparability across samples.

4.3.10 RNA purification and quantitative PCR.
Following serum treatment, MCECs were washed with phosphate buffered
saline (PBS), lysed, and collected for RNA purification. Total RNA was isolated
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using RNeasy Mini Prep Kits (Qiagen) and RNA was reverse transcribed using
High Capacity Reverse Transcriptase kits (Applied Biosystems, lot #-1307187)
prior to quantitative real-time assessment of endothelial markers. Amplification of
target message was performed in TaqMan Universal Master Mix following
manufacturer’s recommended conditions with TaqMan gene expression assays
for TBP(Applied Biosystems Mm00446973), VCAM-1 (Applied Biosystems
Mm01320970), eNOS (Applied Biosystems Mm00435217).

4.3.11 Flow Cytometry for Cell Surface Markers.
Following serum treatment, MCECs were washed with PBS, trypsonized,
and collected in 12x75mm culture tubes (VWR). MCECs were then incubated
with primary antibody for either VCAM-1 (BD Biosciences, Lot #-2117560, FITC
conjugate) or ICAM-1 (BD Biosciences, Lot #-25775, PE conjugate), washed 3x
with PBS, and suspended in 3% BSA. Samples were read on a BD Biosciences
LSRFortessa.

4.3.12 Cell Migration Assay
MCECs were plated on 8-well chamber slides and allowed to come to
confluence. Cells were then scratched with a p200 pipette tip and washed with
PBS before exposed serum was applied to the cells. Chambers were then placed
in a live cell imaging system (Olympus) and a digital image was taken every 15
minutes for 6 hours. Cell area was quantified with ImageJ and plotted over time.
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4.4 RESULTS
4.4.1 Pulmonary Delivery of MWCNT Drives Lung and Systemic Transcriptional
Responses
Representative transmission and scanning electron microscopy images of
the MWCNT demonstrates the relative size and adequacy of dispersion (Figure
4.1). Following exposure to MWCNT multiple markers of inflammation were
increased 10-15 fold in the lungs including systemic pro-inflammatory markers Il6
and Ccl2, as well as Cxcl2; a chemokine secreted by macrophages that acts as a
chemoattractant for neutrophils and stem cells (Figure 4.1).

These effects

persisted at 24 h in a primarily dose dependent manner.
Following exposure there was a 40-80 fold increase of liver enzyme gene
expression, indicative of an acute inflammatory phase response. All responses
were dose dependent with the 40µg dose eliciting a particularly strong response
(Figure 4.1). Responses were elevated at both time points, however by the 24hr
mark expression levels had significantly decreased when compared to 4hrs.
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Figure 4.1: MWCNT characterization by electron microscopy demonstrates the relative size
and adequacy of dispersion.
#

Markers of injury in the lung and liver were increased following exposure. ( p<0.05 vs all groups;
*p<0.05 vs DM, N=6 per group).
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4.4.2 Evidence of BBB Disruption and Neuroinflammation Following MWCNT
Exposure
Immunohistochemistry of the cerebellum and hippocampus in mice 4h
post-exposure to MWCNT revealed elevated GFAP staining, indicative of
activated astrocytes, compared with DM-exposed control mice (Figure 4.2).
Microglia were present, as indicated by IBA-1 staining, but were morphologically
inactive (Supplemental figure 1). PECAM labeling of blood vessels identified
fluorescein leaking in the animals that had been exposed to MWCNTs compared
to DM-exposed controls. (Figure 4.2)
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Figure 4.2: MWCNT (10 ug) exposure acutely induces inflammatory responses in the brain.
Figures A-B, fluorescein in the brain of exposed mice versus vehicle controls. Figures C-H
visualization and quantification of astrocyte activation in the cerebellum and hippocampus. *
indicates a p value of <0.05 by students t test.
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4.4.3 Dependence of MWCNT-Induced Neuroinflammation on BBB Disruption
To specifically delineate whether the neuroinflammation was the result of
loss of BBB integrity, mice were administered vehicle or the rho kinase inhibitor
fasudil, which has been shown to improve BBB function and improve outcomes
in stroke-related models

188,189

. Mice received fasudil either 2h after MWCNT

aspiration, but before injection of the BBB tracer sodium fluorescein, or prior to
MWCNT and again 2 hours later. The former permutation was designed to see if
fluorescein uptake in the brain could be inhibited after exposure and
neuroinflammation had occurred. The latter permutation was to prevent BBB
disruption throughout the time course to test whether neuroinflammatory changes
still occurred in the absence of BBB disruption.
Fluorescein uptake in the brain was significantly enhanced 4h after
exposure to MWCNT (Figure 4.3). This pulmonary exposure was associated
with increased Il6 and CcL5 mRNA expression in cortical regions, and increased
CcL5 mRNA in the hippocampus (Figure 4.3). Treatment with fasudil at 2h postexposure completely blocked fluorescein uptake in the brain, but had no effect on
brain inflammatory outcomes.
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Figure 4.3: MWCNT-induced neuroinflammatory responses are dependent on BBB
disruption.
A. General study design, incorporating a single (1X) fasudil treatment after MWCNT to reduce
brain fluorescein uptake and a preventative (2X) fasudil treatment to prevent MWCNT-induced
BBB disruption throughout the 4h timecourse. B. Fluorescein uptake in brains 4h following
MWCNT aspiration with vehicle, 1X or 2X fasudil treatment. Asterisk indicates significant
difference from control by ANOVA (P<0.05). C. Inflammatory markers IL-6, CCL5 mRNA in the
cortex 4h following DM or MWCNT aspiration. Asterisks indicate a significant effect of MWCNT
compared to control in a 2-way ANOVA (P<0.05) with no influence of the single post-MWCNT
fasudil treatment. D. Preventative (2X) fasudil administration abrogated inflammatory marker
mRNA expression (IL-6, CCL5) in the cortex.
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4.4.4 Dependence of MWCNT induced Neuroinflammation dependent on BBB
disruption
CD36 is a class II scavenger receptor involved in a wide range processes
including fatty acid metabolism190, heart disease, and atherosclerosis191. CD36-/mice showed no increases in fluorescein or pro-inflammatory gene expression in
the cortex or hippocampus 4h following 10µg MWCNT aspiration. (Figure 4.4)
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Figure 4.4: CD36 mice are largely protected from the BBB disruption and
neuroinflammatory effects of pulmonary MWCNT exposure.
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A. Fluorescein uptake in the brain of CD36 mice 4h following treatment with DM or MWCNT. B.
-/Neuroinflammatory markers in the cortex and hippocampus of CD36 .
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4.4.5 Bioactivity of MWCNT-Induced,
Inflammatory Responses

Serum-Borne

Factors:

Endothelial

Microarray analysis was performed on mRNA isolated from endothelial
cells after they had been treated with serum collected from MWCNT-exposed
serum. The results of the microarray revealed induced disease or functional
categories associated with inflammation, immune response, and chemoattraction
/ recruitment of leukocytes. The effect was more prominent in endothelial cells
challenged with serum collected from mice exposed to 40 µg MWCNT. (Figure
4.5).
Application of 10% serum from MWCNT-treated mice on primary murine
cerebrovascular endothelial cells for 4h resulted in a 50% increase in vascular
cell adhesion molecule-1 (Vcam-1) and approximately 3-fold increases in relative
mRNA expression of C-C motif ligand-2 (Ccl-2) and C-C motif ligand-5 (Ccl-5)
pro-inflammatory cytokines in the 40µg dose at the 4hr time point (Figure 4.5AC). The 10µg caused slight increases in Ccl-2 and Ccl-5, but was not statistically
significant.
Similarly, treatment of primary murine cerebrovascular endothelial cells
with serum from MWCNT-treated mice elicited small, but significant up-regulation
of both VCAM-1 and intercellular adhesion molecule-1 (ICAM-1) on the cell
surface, as assessed by flow cytometry (Figure 4.5D,E). By 24hrs the effects
had returned to baseline. These data taken in conjunction with the gene
expression are consistent with activation of the endothelium via canonical NFkB
intracellular signaling pathways.
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Figure 4.5: Inflammatory responses of cerebrovascular endothelial cells treated with
serum from MWCNT-exposed mice.
A. General depiction of assay protocol, with serum from exposed mice incubated on primary
murine cerebrovascular endothelial cells. B. Microarray results indicate numerous transcripts (60)
from serum-treated endothelial cells were elevated in a dose-dependent manner; elevated
transcripts were ontologically related inflammatory and/or cellular defense response. C. Specific
inflammatory genes responses from microarray results. D. Gene ontology graphs showing the
relationships between up-regulated inflammatory genes. E. Confirmation of key inflammatory
mRNA responses by PCR finds that endothelial VCAM-1, Ccl-2, and Ccl-5 mRNA were all
significantly up regulated by serum from MWCNT-treated mice. F. Endothelial cell surface ICAM1 and VCAM-1 protein expression were both elevated by serum from mice exposed to the 40µg
dose of MWCNT as compared to control. Asterisks denote significant difference from DM control
serum (P<0.05).
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4.4.6 Bioactivity of MWCNT-Induced, Serum-Borne Factors: Endothelial Cell
Regrowth and Motility
A scratch assay was employed to assess the functional effects of serum
collected from MWCNT-exposed serum. Serum was applied to confluent
endothelial cells that had been “scratched” with a sterile pipette tip and allowed to
grow back over the course of 6 h. During the regrowth, images were taken every
15 minutes and total cell area was quantified. At the 6 h mark, the controls had
achieved 100 µm of cell growth when compared to 60 µm of growth for the 40 µg
group and 50 µm of growth for the 10µg group. (Figure 4.6) These results were
in complement to the microarray results indicating significantly decreased gene
expression related to cell cycle, mitosis, and cytokinesis which was more
prevalent in endothelial cells incubated with serum collected from mice exposed
to 10 µg of MWCNT (Figure 4.6)
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Figure 4.6: Serum from MWCNT-exposed mice inhibits endothelial cell growth and motility.
A. General depiction of assay protocol, with serum from exposed mice incubated on primary
murine cerebrovascular endothelial cells. B. Ontological classifications of 86 significantly down
regulated genes (noted in Figure 4.5B) suggest loss of cell motility and growth pathways. C.
Gene ontology charts showing the relationship between genes that are down regulated D.Live
cell images of wound recovery, showing the initial edge of endothelial cells (yellow dashed line)
and the edge after 6 h (orange dashed line). E. Mean cell regrowth following wounding in primary
cerebrovascular endothelial cells incubated with serum from DM or MWCNT-exposed mice.
Asterisks denote significant difference from DM control serum effects using a 2-way Repeated
Measures ANOVA (*P<0.05; **P<0.01; ***P<0.001).
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4.5 DISCUSSION
Neurological effects of inhaled particulates have been reported but
considerable uncertainty exists regarding the pathway by which toxic effects
transfer from the lung to the brain. The present study establishes that a
circulating signal arises after pulmonary exposure to MWCNT that leads to a
BBB-dependent neuroinflammatory response. Serum from MWCNT-exposed
mice upregulated adhesion molecules and pro-inflammatory cytokines in primary
cerebrovascular endothelial cells at both the gene and protein level. Serum from
exposed mice also adversely affected the ability of endothelial cells to migrate in
a wound-healing assay. Collectively, these findings implicate a modified serum
composition stemming from pulmonary interactions with MWCNT as a source of
diminished BBB integrity and neural effects.
Severe disruption of BBB integrity has been documented in major
cerebrovascular events or neurological diseases, and BBB permeability has been
directly linked to neuroinflammation. Ischemia/Reperfusion in spontaneously
hypertensive rats has been associated with increased BBB permeability192. MRI
imaging showed increased BBB permeability in people with multiple sclerosis193.
Mouse models of Alzheimer’s disease have found BBB permeability to precede
the formation of the β-amyloid plaques that are the hallmark of the disease194.
Rho kinase inhibition has been shown to reduce neuropathology in
scenarios where BBB is otherwise dysfunctional. Fasudil treatment in a mouse
ischemia model was found to prevent BBB permeability as well as the formation
of oxidative stress189. Rho kinase inhibition with fasudil has been shown to
116

accelerate functional recovery in different mouse and rat spinal cord injury
models, with fasudil given locally or systemically after injury195-197. Autoimmune
demyelinating disorders, such as multiple sclerosis, have been treated with Rho
kinase inhibitors with great success. It is thought that Rho kinase inhibition in
these disorders prevents the leukocyte migration into the central nervous
system198.
The class B scavenger receptor CD36 mediates free radical production
and brain injury in cerebral ischemia199. It has also been shown to activate the
Rho/Rho kinase pathway200. Our lab has found CD36 to play a key role in
mediating vasorelaxation as a result of ozone exposure110. Loss of CD36
prevented both the BBB permeability and neuroinflammation that was associated
with MWCNT exposure, suggesting an important role for CD36 activation.
Inhalation of PM has been associated with neuroinflammation and BBB
integrity deficits

201,202

, but this is the first study to show a mechanistic link

between the two outcomes. Oppenheim et al identified significant increases in
brain fluorescein uptake resulting from long-term exposure (50d) to a mixture of
gasoline and diesel emissions in ApoE-/- mice
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. These findings were similarly

associated with increased cerebrovascular gelatinase levels and reduced
occludin and claudin-5 expression and, in parallel, increased inducible nitric
oxide synthase expression in the brain parenchyma. Rats exposed to diesel
emissions for 6 months demonstrated significant increases in cortical TNFα, αsynuclein, and Aβ42 expression

204

. Importantly, all of these studies involved
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long-term exposures, while the present study reveals effects within 4h of
pulmonary MWCNT exposure.
Unique to this study is the idea that serum is able to drive disparate
endothelial responses at multiple levels, consistent with a complex activation of
multiple homeostatic responses at varying dose-response relationships. Due to
the nature of the modifications in the serum there exists the possibility of
activating multiple endothelial cell surface receptors, thereby eliciting a wide
range

of

cellular

responses.

Our

lab

and

others

have

shown

that

immunomodulatory scavenger receptors, such as CD36110,113, TLR4114, and
LOX-1115 play a major role in eliciting endothelial inflammatory and antidilatory
responses following exposure to various inhaled toxicants. Further study will be
required to elucidate the principal ligand/receptor interactions responsible for
activating the inflammatory responses.
Alternate pathways, such as direct delivery of inhaled particulates and
CNTs have been hypothesized, but limited evidence exists demonstrating
substantive transference of CNTs across the BBB, and no evidence for a direct
biological effect has been mechanistically established in such studies.
MWCNTs, specifically, accumulate in the brain in only small fractions of the
original pulmonary dosage (0.001% of the lung burden at day 1 post-inhalation
for 12 d), and specific confirmation that the material has penetrated beyond the
capillary wall is often lacking in distribution studies, i.e., much of the residual
mass of CNTs may simply reside in the cerebrovascular compartment and not
the brain tissue. CNTs, and specifically MWCNTs, have many characteristics
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that make them highly desirable as drug delivery platforms. The ability to
withstand a high degree of functionalization is perhaps their most desirable
feature. Many labs have employed MWCNTs as the basis for the targeted
delivery of numerous compounds to different organs. MWCNTs were used to
deliver Doxorubicin to brain glioma cells. The MWCNTs were PEGylated with
angiopep-2 in BALB/c mice engrafted with C6 glioma cells. While the authors
were able to discern a statistically significant amount of doxorubicin in the brain
when compared to controls, they were unable to conclude that this route of
delivery would be clinically relevant205, despite extensive engineering efforts to
target the brain206.
MWCNTs are able to withstand a high degree of functionalization,
including surface coating, attachment of fluorescent linkers, and drug delivery
insertion207. These manipulations are able to decrease the amount of toxicity that
MWCNTs can induce208, as well as allowing for less aggregation209 and better
clearance by the body210. However targeting of CNTs to specific locations in the
body is still very difficult205,211,212. Targeting CNTs to the brain adds an extra layer
of complexity when the BBB is taken into account. This specialized structure has
proven to be especially adapt at keeping functionalized MWCNTs out of the
brain213.

Other labs have investigated both the in vivo biodistribution and

pharmacokinetics of various permutations of drug delivery systems that were
built on a MWCNT platform. Singh et al found that MWCNT-GEM complex with
FA targeting in rats accumulated in major organs including the liver, lung, kidney
and spleen214. Moore et al investigated the biodistribution pattern of PLA-PEG119

coated MWCNT loaded with PTX. Intravenously (IV) injected CNTs in mice
showed accumulation in the lungs, liver, and spleen. These particular CNTs did
show a lack of an inflammatory response when compared to controls215.
Future analysis of the serum will be required to better understand the
nature of the systemic effects that occur as a result of MWCNT exposure. While
our proteomics data denotes a number of modified proteins following exposure
(personal communication with Dr. Andrew Ottens), it is important to keep in mind
that the analysis was only conducted on the fraction of the serum that was <5Kd,
creating the possibility that larger proteins could also be affected. Lipidomic
analysis could also provide information on the nature of the serum due to the
potential for MWCNTs to interact with lipids in the lung.
In conclusion acute, occupationally relevant doses of MWCNTs are able to
induce neuroinflammation dependent on BBB permeability. These effects seem
to be driven in part by an as yet identified serum signal that is able to drive
inflammatory outcomes in naïve endothelial cells.
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Discussion
Epidemiological studies established the adverse cardiovascular health
effects of air pollution in the early 90’s216. Increasing evidence found that
particulate matter, specifically PM2.5, was able to drive a wide range of
cardiovascular effects including chronic cardiovascular disease progression217 to
increased incidence of myocardial infarction218 and even death219. With these
effects established, researchers began to investigate the mechanisms through
which inhaled particulates were able to induce systemic cardiovascular effects.
While no single mechanism was identified, it soon became clear that smaller
particles were significantly more toxic than larger particles.
The advent of nanotechnology created a new field of toxicology focused
on particles that were <100 nm in any dimension. The size of these particles
gave them unique physiochemical properties that required investigation into both
their local and systemic effects. Several studies were able to establish both the
time course and magnitude of pulmonary toxicity resulting from inhaled
nanoparticles; however, their systemic extrapulmonary effects and underlying
mechanisms have only recently come under investigation.

4.6 Novel Methodology to Assess “Spillover” Hypothesis
As evidence accumulated indicating that CNTs were unable to directly
translocate from the lungs into the systemic circulation in significant amounts,
other mechanisms began to receive more attention. More focus was placed on
the spillover mechanism. Our lab embraced this idea with a focus on the serum
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component of the blood carrying an “inflammatory signal.” This relatively
unbiased approach is advantageous on many levels. It allows for a more holistic
assessment of the serum, as opposed to focusing on individual serum
components and trying to draw broad conclusions. It also allows for a more
anatomically appropriate approach as serum (but not particles) comes in direct
contact with endothelial cells. Utilization of the serum allows for the almost
complete removal of any particles that may make their way into the circulation,
with the filtration of anything >10 kDa (as in Chapter 3) ensuring that there are
neither particles nor even cytokines driving the observed vascular effects. This
approach, however, did enable us to assess the potential for MMP9 degradation
products that entered the circulation to mediate serum bioactivity.
This approach does have important drawbacks, however. The complex
nature of the serum makes it difficult to identify individual molecules with
biological activity that drives adverse outcomes. Despite removal of large serum
components, many small molecules, lipids, lipoprotein particles, proteins, cells
and subcellular material remain. It is clear from our studies that particles,
especially MWCNTs, create an altered bioactivity that is pro-inflammatory and
anti-dilatory. Nonetheless, the molecular mechanism(s) by which the circulation
becomes bioactive likely involves complex pathway arising from particle
interactions in the lungs. Future –omic approaches will be necessary to provide
insight into those complex, pathways and to identify the specific molecules that
are modified.
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4.7 Analysis of the Lung response to MWCNTs
The lungs have the largest surface area of any organ in the body. This
makes them especially vulnerable to the effects of airborne pollutants. They are
not, however, without their own defense systems that facilitate clearance or
metabolism to mitigate the adverse effects of inhaled toxicants.
Due to their size, MWCNTs are able to reach and deposit in the alveolar
regions of the lungs180. Deeply deposited particles cannot be easily or rapidly
cleared via the mucociliary escalator and instead must be cleared through the
activation of alveolar macrophages, which effectively phagocytize PM to remove
them from the lungs. As a result of activation, the macrophages secrete proinflammatory cytokines and other enzymes. Analysis of the BALF has found that
there is also an increase in neutrophil infiltration following MWCNT exposure.
Neutrophils clear pathogens in part via generation of ROS220. This process is not
well controlled and can result in damage to the surrounding tissue. Combined
with the increased endothelia-epithelial permeability (as observed by an influx of
albumin) and edematous changes, MWCNT exposure creates a very proinflammatory environment in the lung.
At present, the chemical changes in the lung resulting from this proinflammatory environment are not sufficiently well understood to draw
conclusions related to functional systemic outcomes. Nanoparticle exposure
creates the potential for modified proteins and lipids in the epithelial lining fluid,
as well as pro-inflammatory cytokines and oxidative stress. Because such
reactive intermediates form in the alveolar region of the lung, it creates the
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potential for some spillover into the systemic or lymphatic circulation, although
specific pathways by which reactive intermediates gain access to these
compartments

is

unclear.

Furthermore,

which

intermediates

and

the

concentrations, thereof, actually attaining access to the systemic circulation is
currently unknown. Proteomics analysis by Dr. Andrew Ottens (VCU; personal
communication) has found that a large number of fragmented proteins are found
in the serum component of the blood following exposure to MWCNTs. While this
is consistent with outcomes related to MMP activation, it does not preclude the
possibility that modified lipids, adducted/modified proteins or secreted peptides
from activated macrophages are being generated and making their way into the
systemic circulation. Dr. Ottens found approximately 1500 modified proteins in
the serum following exposure of mice to MWCNTs and the findings were
consistent with serum changes following ozone exposure. Identifying the proteins
of pathological relevance remains to be determined, and it would be valuable to
examine proteomic signatures in the lung to examine whether serum molecules
arise from the airways. Dr. Ottens removed all the proteins in the serum that
were larger than 10 kDa to focus on those factors most likely to penetrate a
disrupted BBB. This suggests that any effects observed with this fractioned
serum are independent of any MWCNTs that may have translocated directly from
the lungs into the systemic circulation.

4.8 Analysis of the Systemic Vasculature following MWCNT exposure
The reactive intermediates that were generated in the lungs and spilled
over into the systemic circulation have the potential to create a wide range of
126

adverse effects. One possible effect is the disruption of endothelial homeostasis.
Under normal conditions the endothelium functions to maintain an antiinflammatory environment and regulate blood flow to peripheral organs. Once the
endothelium is “injured” or adversely perturbed, it becomes activated and begins
to mount a response221.
Initial activation of the endothelium involves two key outcomes. First the
endothelial cells begin to upregulate the expression of adhesion molecules, such
as ICAM-1, VCAM-1, and p-selectin. By interacting with EC adhesion molecules,
circulating leukocytes are able to adhere, roll, firmly tether, and eventually
transmigrate into the tunica intima. In the case of monocytes, this transmigration
into the tunica intima causes them to transform into macrophages, significantly
increasing their ability to phagocytize cellular debris or other macromolecules
and activate TH1 cells222. Macrophages in the vascular wall are central to the
progression of atherosclerosis223.
The second consequence of the activation of the endothelium is the loss
of eNOS function. eNOS is very cardioprotective, exerting anti-inflammatory, anticoagulatory, and anti-migratory effects. It is also one of the chief proteins
responsible for vascular smooth muscle cell relaxation and vasodilation. Under
normal conditions, eNOS exists as a dimer, with tetrahydrobiopterin (BH4) acting
as a key cofactor that facilitates electrochemical coupling. It is important to note
that BH4 is also an excellent scavenger of superoxide anion224. When
intracellular oxidative stress increases, eNOS can be “uncoupled” due of a loss
of BH4 and transformed into a superoxide anion-generating monomer225. This
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uncoupling and superoxide anion generation further contributes to the prooxidative and pro-inflammatory environment.
The combination of an activated endothelium and a loss of eNOS
functionality is central to the early stages of vascular disease pathogenesis.
Protein and lipid components of low-density lipoprotein can be oxidized leading
to

stimulation

of

CD36226

and

enhancing

lipoprotein

phagocytosis

by

macrophages, which then differentiate into foam cells. Foam cells reside at the
site of injury and continue to secrete chemoattractant cytokines227. The activity
and accumulation of the resultant foam cells help determine the behavior of the
plaque. MMPs can also become secreted and induce rupture of the plaque.
Over time, plaques form as a result of this vascular injury and endothelial
activation. Lesions can be either stable or unstable, depending on the nature
and composition of the plaque. Other factors outside of environmental PM
exposures can have a large influence the pathogenesis of plaques, such as age,
diet, lifestyle, and genetics. Plaque stability determines long-term health effects.
Stable plaques lead to cardiac symptoms when oxygen demand rises228.
Unstable plaques can rupture and contribute to vessel occlusion, which can
result in thrombosis229, stroke230, or myocardial infarction231, depending on the
affected vessel bed. This process of atheroma formation and destabilization
takes a long time to develop and is generally asymptomatic until a major health
event occurs.
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Several studies have examined the ability of nanomaterials to induce
atherosclerosis. Cao et al. showed that two different types of MWCNTs were able
to provoke progression of atherosclerosis in the aorta when compared to control.
The model used in this study was an ApoE-/- mouse on a high fat diet, where
cholesterol levels in excess of 1000 mg/dl can be achieved and atheromatous
lesions develop over the course of several weeks, progressing to advanced
lesions in a year. Wild type mice on normal chow diets do not develop aortic
plaques in their aorta due to their ability to rapidly remove LDL. This study also
employed two different kinds of MWCNTs. The MWCNTs in this study were from
Nanocyl with a diameter of 30 nm, slightly smaller than the more commonly used
Mitsui-774. Mice were dosed with 25.6 µg of MWCNTs once a week for 5 weeks
via ITI dosing. Total plaque area in the aortic root was increased compared to
controls, which was associated with increased pulmonary inflammation.
Interestingly, circulating cytokines were not changed compared to control. An
earlier study by Li et al. investigated the cardiovascular effects of SWCNTs. They
also utilized an ApoE-/- mouse model and exposed mice to four doses of
SWCNTs at 20 µg/dose of particles via pharyngeal aspiration. Thoracic aorta
was formalin fixed and total plaque area was quantified. Histological assessment
of lesions in mice confirmed that SWCNT were able to significantly increase
lesion progression when compared to controls74.

Thus, chronic, repeated

exposures to nanomaterials can promote vascular disease. Despite the shortterm study design employed in the present research, our outcomes are
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consistent with the idea that, over time, the serum factor-induced endothelial
activation may exacerbate vascular disease.
It is not presently known what components of the serum are interacting
with the endothelial cells, and which receptors are being activated. Evidence
from our lab and others implicates a strong role for scavenger receptors. These
receptors, such as LOX-1115, toll-like receptors232, and various clusters of
differentiation markers113, bind a wide range of peptides in addition their native
ligands. Our lab in particular has found LOX-1 and CD36 in the vasculature play
important roles. These studies bolster the concept that serum-borne ligands drive
endothelial cell activation following pulmonary exposure to particles. Given the
overlap in findings, it remains to be seen how such multiligand receptors may
cooperate or interact on the cell surface to promote intracellular responses.

4.9 Analysis of the BBB following MWCNT exposure
At present, few studies have mechanistically examined neurological
effects

related

to

inhaled

pollutants.

Studies

that

have

investigated

neuroinflammation following exposure have reported inconsistent effects. Ozone
exposure at 1 ppm for 60 and 90 days was shown to result in pro-inflammatory
gene expression in the hippocampus of adult rats186. Diesel exhaust exposure
across a range of concentrations ranging from 0-1.0 mg/m3 for 6 months was
found to increase pro-inflammatory protein expression and increase signs of
Alzheimers in rats204. No clear mechanism has been established for these
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effects, but the present study highlights the potential for BBB deficits to be a
central player.
Because we hypothesize that translocated particles are not the direct
driver of neuroinflammation, we addressed the more proximal interaction
between serum and the BBB. This study focused on the permeability of the BBB
following a bolus exposure to 10 µg MWCNT-7. This dose was chosen due to
ability of MWCNT-7 to induce a greater vascular dysfunction in numerous assays
as compared to a dose of 40 µg. The scavenger receptor CD36 and modulation
of BBB permeability were chosen to identify potential mechanisms responsible
for the neuroinflammation found in our model.

4.9.1 BBB permeability
Following nanotube exposure, evidence of neuroinflammation was found
in the brain, as characterized by increased pro-inflammatory gene expression in
the cortex and hippocampus and activation of astrocytes. BBB impairment was
also noted by the increased brain uptake of the fluorescent tracer fluorescein. A
single dose of fasudil 2 hr after MWCNT exposure prior to fluorescein injection
was able to mitigate the uptake of fluorescein in the brain, but inflammatory gene
expression was still modestly elevated. However, prophylactic treatment with
fasudil maintained BBB integrity after MWNT exposure and blocked cortical and
hippocampal Il6 and CcL-5 mRNA induction.
Aside from its high affinity for ox-LDL, CD36 has also been shown to
activate the Rho kinase pathway and tyrosine kinases associated with
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constriction in a Ca2+ independent manner200. Fasudil works to inhibit the Rho
kinase pathway, allowing the actin cytoskeleton to relax and effectively maintain
BBB permeability. Loss of CD36 or inhibition of Rho kinase via administration of
fasudil both effectively maintained the tight junctions of the cerebrovascular
endothelium and prevented neuroinflammation after MWCNT exposure.
Consistent with our findings, inhibition of Rho kinase has been found to prevent
ischemia induced injury189. (Figure 5.1)
Astrocytes are the most abundant cell type in the brain and have been
associated with a wide range of processes including BBB modulation,
maintenance of neurons, and regulation of ion gradients. Their activation as a
result of nanotube exposure appeared dependent on the increased BBB
permeability also observed, and is possibly a sentinel effect of further
neuropathologies that could emerge from nanoparticle exposure. Due to their
multitude of functions it is difficult to determine what other roles astrocytes might
be playing aside from their role in providing support to the BBB. Further efforts to
characterize a range of doses and time course of exposure would be informative
as to the potential that astrocyte activation promotes adverse neurological
outcomes.

4.10 MMP-9 Activation in the Lungs
The origin of bioactive ligands that activate EC scavenger receptors is
postulated to be particle interactions in the lung microenvironment. Several lines
of evidence, including gene and protein expression in the lung, suggested that
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MMP-9 might be playing a major role in the generation of such ligands.
Proteomic analysis by Dr. Andy Ottens (personal communication) identified a
wide array of modified proteins in the serum following nanotube exposure.

Figure 5.1: Ox-LDL can induce CD-36 signaling pathways leading to phosphorylation of
MLCP and MLCK.

Peptide sequencing of the smaller fraction (<10 kDa) of these proteins led to the
realization that many originated from ECM substrates, suggesting a role for
MMP-associated proteolysis. It is important to remember that even under
homeostatic conditions, MMPs generate numerous protein fragments that can
possess biological activity. Activation of MMPs as a result of nanotube exposure
could result in prolonged MMP production/secretion and continued generation of
novel, circulating fragments with unknown biological activity.
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4.10.1 MMP-9 Activation
Macrophages are a major source of MMP-9 secretion233. Analysis of the
bronchoalveolar lavage fluid following nanotube exposure found increased
alveolar macrophage activation, opening the door for significant MMP-9 secretion
as a result. It is important to note that protein fragments that are generated by
MMP-9 as a result of nanotube exposure may be novel, and as such may contain
unknown structures. These novel protein fragments carry the potential for further
modifications, depending on their structures, which could result in greater levels
of biological activity than protein fragments that are generated under baseline
conditions. (Figure 5.2)
Measurement of MMP protein or gene expression is insufficient to
demonstrate functional changes; rather, the activity of the MMP enzyme must be
assessed. This can be accomplished through the use of zymography (either in
situ or electrophoresis gel-based) to assess an active MMP. MMP activation can
be mediated through multiple mechanisms including xanthine oxidase activity234,
convertases235, or reaction with the cysteine switch, leading to activation236. This
required cleavage of the pro-MMP for activation suggests a role for other MMPs
as well. While the focus of this study was MMP9, there was no assessment of its
activity level, which remains a significant gap in the present research. Other
MMPs, such as MMP2, were not highly expressed following MWCNT exposure,
but their activity level could have been altered, potentially contributing to
systemic serum bioactivity. Like MMP9, the prototypical substrate of MMP2 is
gelatin making it the most likely alternate MMP to be playing a role.
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Figure 5.2: Schematic Representation of Experimental Results.

4.11 Pathological Outcomes of Novel Protein Fragments
Novel protein fragments that are generated as a result of MMP-9
activation and nanotube exposure create the potential for different pathological
outcomes. Damage Associated Molecular Patterns (DAMPs) are molecules that
can initiate and perpetuate immune response in the noninfectious inflammatory
response237. Protein DAMPS include heat shock proteins238, High Mobility Group
Box 1 (HMGB1)239, and extracellular matrix fragments including hyaluronan
fragments240. There exists the potential for the formation of protein-based
extracellular fragments that can bind TLR2, TLR4, and Receptor for Advanced
Glycation Endproducts (RAGE) resulting in pro-inflammatory cytokine secretion
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(IL-6, IL-1, IL-8) as well as up-regulation of adhesion molecules (ICAM-1, VCAM1) on endothelial cells.
A second pathological outcome involves the formation of a neoantigen
and autoimmunity. This would likely be mediated by a T cell response, with a
TH17 response being the most likely outcome. TH17 overaction against an
autoantigen will cause type 3 immune complex and complement mediated
hypersensitivity. In the case of novel protein fragment generation, a neoantigen
may be formed that would then be processed by antigen presenting cells (APCs)
allowing for activation of TH17 cells and an autoimmune response.

4.12 Health Outcomes
4.12.1 Acute
The results of this work highlight the possibility for myriad adverse
cardiovascular and neurological health outcomes, both acute and chronic,
resulting from MWCNT exposure. The myography data suggest the potential for
aortic stiffness and vasoconstriction, which could lead to increased blood
pressure, and/or impaired perfusion to specific (or vulnerable) vascular beds.
Vascular inflammatory outcomes may predispose to more serious sequelae
following exposure, include stroke or myocardial infarction. Localized vascular
activation of MMP9 could act to degrade/destabilize vulnerable plaques. These
outcomes would depend on several factors including an individual’s disease
state, lifestyle, genetics, and diet112.
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Chronically, the most likely outcome of concern related to MWCNT
exposure outside of the lung is the development and progression of
atherosclerosis. Because atherosclerosis is a disease that can manifest in
several different ways over a long period of time, the impact of inhaled
nanomaterials would largely influence existing pathologies. Plaques may be
stable and have few health consequences, or the plaque could rupture leading to
major health complications. It is heavily dependent on a combination of factors
and time that vary from person to person.
The increased BBB permeability and resultant neuroinflammation also
create the potential for neural pathologies. Alzheimer’s disease, in particular, has
been hypothesized to involve a breakdown in the BBB and death of astrocytes,
resulting in formation/accumulation of insoluble plaques. Because Alzheimer’s is
not well understood, it is unclear whether increased BBB permeability drives
disease progression or if it exacerbates symptoms as a result of activation of
resident immune cells in the brain241. Multiple Sclerosis, an autoimmune disorder,
has also been associated with increased BBB permeability. In the case of MS,
the increased permeability of the BBB results in an influx of T cells that attack the
myelin sheath of neurons, rendering them incapable of transmitting nerve
impulses242. Importantly, the serum-based functional assays employed in the
present research offers a unique and translational means of confirming the
contributions of nanotube-induced blood-borne factors to driving chronic disease
outcomes.
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4.13 Integration and Synthesis of Findings
4.13.1 Modified Endogenous Lipids, Proteins, and Scavenger Receptor Signaling
This work highlights the importance of scavenger receptors, particularly
CD36, and the role they play in mediating systemic effects following MWCNT
exposure. Thrombospondin-1 (TSP-1) is the endogenous ligand for CD36243.
TSP-1 is a very large protein, but its binding sequence consists of 30 amino
acids that are acidic in nature and common to other proteins, especially those in
the extracellular matrix. Serum compositional analysis is needed, specifically
peptide sequencing of the protein fragments that arise from nanotube exposure,
to facilitate comparison with the TSP-1 binding sequence. Such sequencing will
help to confirm whether consensus sequences for CD36 binding are elevated in
the serum after MWCNT exposure, and the degree to which MMP-9 is a key
mediator generating those peptide fragments.
Ox-LDL binds CD36 with a very high affinity244. Classic lipid panels do not
measure circulating ox-LDL levels, but with mounting evidence implicating the
inflammatory effects of ox-LDL, extra effort to assess the protein/lipid
modifications of LDL would be valuable given the role for CD36 in driving
environmental effects. Circulating ox-LDL levels could be measured and
compared between control and experimental groups; previous studies of engine
emissions show increased ox-LDL in mice and humans. If ox-LDL is elevated, a
neutralizing antibody could be used against ox-LDL115 and eNOS mediated
relaxation could be assessed to determine the inflammatory potential of the
serum.
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4.13.2 T cells
As

evidence

mounts

implicating

the

role

of

inflammation

in

atherosclerosis, recent studies have begun to support a role for T cells. T cells
control the adaptive arm of the immune system, and as such their activation is
tightly regulated. Aberrant activation of T cells has been implicated in many
systemic autoimmune diseases including rheumatoid arthritis245, type I
diabetes246, atherosclerosis247, and systemic lupus erythematosus248. A study by
Lim et al investigated the relationships between proatherogenic factors and
autoimmunity. The authors used LDb mice, mice that lack both the LDL receptor
and apolipoprotein B receptor develop atherosclerosis on a normal chow diet,
which created an environment that was favorable for Th17 cell polarization of
autoreactive T cells. Moreover, when dendritic cells took up ox-LDL it resulted in
secretion of IL-6 Th17 cell polarization249.
Evidence from our model provides indirect evidence for T cell activation,
namely the ability of the serum to up-regulate the expression of CcL-5 when
incubated on naïve endothelial cells, and up-regulation of CcL-5 in the brain
following exposure to MWCNTs. CcL-5 is chemotactic for T cells and plays an
active role in recruiting leukocytes to inflammatory sites. The BBB is an area of
intense research. It was generally thought that the only factors that were able to
cross the BBB were water, oxygen, and vitamins/nutrients. However, recent
studies have discovered the ability of T cells to cross the BBB250. (Figure 5.3)
At present there are three main mechanisms through which the BBB can
be compromised: the BBB contains a limited number of transporters that can be
139

used to transport cytokines; certain cytokines have shown the ability to destroy
the tight junctions of the endothelial cell layer of the BBB; and there also exists
certain regions of the brain where the BBB is not full developed250.
Kipnis et al. recently established the unique lymphatic system associated
with the BBB. The authors found functional lymphatic vessels lining the dural
sinuses. These structures express all of the molecular hallmarks of lymphatic
endothelial cells, are able to carry both fluid and immune cells from the
cerebrospinal fluid, and are connected to the deep cervical lymph nodes. Their
discovery allows for a reassessment into the processes of neuroimmunology and
neuroinflammation251. This system allows for one potential mechanism through
which T cells could bypass the BBB.

Figure 5.3: Potential Mechanism for T cell migration into the Brain

252

T cells cross the first layer of the BBB in manner similar to the periphery. There exists a second
layer they must cross that requires activation of MMP9.
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In addition to crossing the BBB, circulating inflammatory cells need to
cross a second layer composed almost entirely of astrocytes. The process by
which T cells traverse this layer is not well understood. There does seem to be a
role for MMPs, specifically the gelatinases (MMP-2,9), but more work is needed
to understand the interactions that are occurring at this junction253,254. MMP-9 is
thought to play an essential role in destroying the tight junctions at this second
layer, suggesting the loss of MMP-9 in our model would result in a
neuroprotective effect.
To assess the potential for T cell involvement following particle exposure,
T cell populations in the circulation could be measured by flow cytometry. T cell
function could also be assessed if T cell populations are unchanged between
groups. Staining for the presence of T cells in the brain following exposure would
help substantiate the purported role for CcL-5. The presence of T cells in the
brain following nanotube exposure would be interesting and simultaneously raise
several questions related to the mechanism of recruitment and their
functional/pathological role in the brain.

4.14 Study Caveats
All studies have their shortcomings. The present work relies on bolus
doses of nanotubes delivered to the lungs and short time courses for health
outcome assessment. Even though studies have shown that PA and inhalation
result in similar effects255, inhalation studies would allow for a more accurate
assessment of the effects of nanotube exposure. In pilot studies, we did show
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some consistency of bioactivity in serum from mice exposed to 5 mg/m3 MWCNT
for 6 h/d x 19 days. This work was developmental, though, and follow-up is
required to better understand the severity of effects and establish a no-effect
level.
Similarly controlled human studies would also provide more insight into
the acute and chronic effects of nanotube exposure. Current workplace exposure
results in a wide range of doses and particle configurations. Controlled studies
would provide greater insight as to the dose, time course, and particle forms are
most likely to cause adverse health effects. Additionally, the substantial variability
in health, genetics, and lifestyle may impact the outcomes of pulmonary MWCNT
exposure and the impact of these factors was not addressed in the present
study. Thus, future human studies would help to establish the variability in
biological responses that occur as a result of these variables.
Lastly, this study relies on acute exposure periods. Long-term studies are
needed to determine if chronic inflammatory diseases or adaptive immune
changes result from repeated exposure or a longer period before sacrifice. The
development of atherosclerosis requires many weeks, sometimes months, even
in specially engineered mouse models. Longer-term studies would provide more
concrete evidence as to the ability of the body to adapt to such exposure
challenges, or if it is unable to overcome the repeated acute effects of vascular
inflammation, endothelial dysfunction, and BBB impairment.

142

4.15 Conclusions
This work establishes the serum-borne bioactivity as a key mediator of the
systemic effects that can occur as a result of particle exposure. Endothelial cells
are particularly sensitive due to their anatomical location and their role in
maintaining homeostasis in the blood vessels. Under basal conditions MMP-9
generates ligands with known bioactivity. MWCNT exposure causes enhanced
MMP-9 levels presumably resulting in the generation of new/altered ligands,
some of which are potentially unknown structures, which further contribute to the
bioactivity of the serum. The altered composition of the serum is able to
adversely affect vessel relaxation, as well as induce cerebrovascular/neural
inflammation both in vitro and in vivo.
The results of this study highlight the importance of the scavenger
receptor CD36. The ability of CD36 to bind a wide range of ligands and activate a
myriad of responses with other cell-surface proteins further confirms its
importance. Loss of CD36 in the vasculature and the BBB was protective against
the effects of inhaled MWCNTs. The BBB is specialized region of the brain that
contains a high number of tight junctions between the endothelial cells. This work
ascertains the ability of nanotubes to induce BBB permeability, resulting in
neuroinflammation in the cortex, and cerebellum. Serum from exposed animals
was able to up-regulate adhesion molecules and pro-inflammatory cytokines
when incubated on naïve cerebrovascular endothelial cells. Taken together,
nanotube exposure induces serum compositional changes that destabilize the
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BBB and stimulate neuroinflammation, potentially explaining cardiovascular and
neurological impacts of inhaled PM.
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